View Article

  • Nature’s Cure: The Impact of Medicinal Plants on Oxidative Stress and Inflammation in Cardiovascular Diseases

  • SMBT College Of Pharmacy Dhamangaon, Nashik 

Abstract

Chronic inflammation and oxidative stress play a crucial role in the progression of cardiovascular diseases (CVD), including conditions such as myocardial infarction, hypertension, and atherosclerosis. The report highlights the therapeutic potential of naturally occurring bioactive compounds such as flavonoids, phenolics, and other phytochemicals found in various medicinal plants. These compounds exhibit cardioprotective effects by modulating inflammatory pathways, reducing oxidative damage, and improving endothelial function. Furthermore, this review discusses several medicinal plants, detailing their bioactive components and mechanisms of action, underscoring their potential as natural agents for reducing cardiovascular risk. This review explores the potential application of antioxidant and anti-inflammatory medicinal plants in the treatment of CVD.

Keywords

Cardiovascular Disease, Antioxidant, Anti-inflammatory, Myocardial Infarction, Hypertension, Medicinal Plant

Introduction

Cardiovascular disease (CVD) encompasses a range of conditions that affect the heart and blood vessels and is becoming increasingly prevalent worldwide. The rising incidence of CVD highlights the need for effective prevention and treatment strategies. Chronic illnesses, including CVD, are driven by various risk factors, with inflammation and oxidative stress playing key roles in disease progression (1). CVD is the world's biggest cause of death. More than 75% of deaths in low- and middle-income countries are caused by CVDs. In 2016, around 17.9 million deaths globally were attributed to CVDs, accounting for 31% of all fatalities. Eighty-five percent of these deaths were caused by heart attacks and strokes(2)Since the World Health Organisation (WHO) claims that over 75% of premature CVD cases are avoidable, improving the risk factors that are linked to CVD can significantly lessen the increasing burden of CVD on patients and healthcare providers(2). The World Health Organisation (WHO) states that over 75% of early CVD cases are preventable, hence reducing the associated risk factors can greatly lessen the growing burden of CVD on individuals and healthcare platforms(3).

One of the main causes of death worldwide is cardiovascular disease (CVD). Along with the rising rates of obesity, Type II diabetes, and hypertension, nations like India are having difficulty managing the impacts of CVD. Compared to Western countries, heart disease appears 10 to 15 years sooner in India(4). Hyperlipidaemia, which is caused by aberrant metabolism of fats, is a common cause of many long-term conditions, including cardiovascular disease (CVD). Cardiomyopathies, heart failure, heart attacks, coronary heart disease, hypertension, dyslipidaemia, and peripheral blood vessels disorders are all included in the category of heart disease (CVD). Around the world, CVD is the primary reason for both sickness as well as death. Cardiovascular disease currently accounts for more deaths among women than breast cancer. Among the nonmodifiable risk factors for cardiovascular problems, age and sex are most commonly cited. Heart-related diseases are more prevalent as people age. High blood pressure, elevated low-density lipoprotein, excessive alcohol intake, elevated psychological stress, cholesterol, inactivity, diabetes mellitus, abdominal obesity, and smoking are risk factors for cardiovascular disease(5). Inflammation of the arterial blood vessels is the primary cause of rheumatic heart condition, arterial thrombosis, pulmonary embolism, brain-vascular and peripheral arterial illnesses, and coronary heart disease (CHD).  A number of danger signs for cardiovascular diseases (CVDs) can be changed or avoided, such as poor eating habits, diets heavy in carbohydrates and low in protein, smoking, excessive alcohol use, diabetes mellitus, obesity and physical inactivity, high blood pressure, excessive consumption of red meat and saturated fats, sugary drinks, and excessive salt intake (6). Because endothelial cells' ability to suppress inflammation is diminished due to a decrease in nitric oxide (NO) availability, growth factors on the cell membrane and Chemoattractant can be produced by platelet activation, setting off a series of inflammatory reactions. Compounds with antioxidant and anti-inflammatory qualities, in addition to those that provide protection for the vascular endothelium, will be essential in the management of heart conditions. Medicinal plants include bioactive compounds that carry out these crucial functions(1) The risk of cardiovascular diseases (CVDs) and LDL cholesterol levels are strongly influenced by diet and lifestyle. Guidelines for Changes in lifestyle that lower fat and cholesterol intake, abstain from tobacco products, and maintain a healthy body mass index (BMI) through sufficient physical exercise should be given to those with CVDs. A BMI over 25 has been linked to a higher risk of CVDs, while a BMI below 20 is usually not advised. The lowest risk is seen in the 20–25 BMI range(1). 

Cardiovascular Diseases 

Acute myocardial dysfunction

In relation to COVID-19, the majority of commonly documented cardiovascular consequence is acute myocardial damage. Different definitions of acute myocardial damage have been used in different investigations. These definitions include abnormalities in the ECG and/or elevated cardiac enzyme levels (using different biomarkers and thresholds). Nonetheless, the most often recognised criterion is an increase in high sensitivity cardiac troponin I (cTnl) above the upper reference range of the 99th percentile. There has been variation in the total number of cases of acute heart damage; in about 8–12% of confirmed cases, there was a notable rise in cTnI levels (7). The previously published meta-analysis of the Chinese research revealed an 8% risk of acute heart injury(8), whereas a different study that only included patients with a clear result (either death or hospital discharge) revealed a 17% rate of cTnI elevation (9). Whether or not acute cardiac damage actually occurs, it has been repeatedly found to be a major poor forecast indication Among individuals with COVID-19,(9–11). Increased troponin levels are substantially more common in patients who are confined to the critical care unit or who suffer from serious or fatal illnesses. On the other hand, patients with minor diseases who do not require intensive care unit admission are very unlikely to have increased troponin levels (only 1-2%).

Arrhythmias
In COVID-19 patients, bradyarrhythmia and tachyarrhythmias are known to occur. As per study that examined the clinical features and results of 138 COVID-19 patients in China, the incidence of arrhythmia was 16.7% (11). At 44.4%, this incidence was far greater among patients hospitalised to the intensive care unit than it was among those who did not require ICU treatment, which was just 8.9%. It was unclear what kinds of arrhythmias were involved.

Hypertension

Over 20% of the general population suffers with hypertension, making it the most common ailment in developed nations. Despite the fact that numerous according to clinical research, decreasing blood although pressure lowers the risk of myocardial infraction and stroke, it significantly raises the risk of heart failure, stroke, myocardial infraction, and renal failure (12). Numerous environmental and genetic factors make it challenging to assess blood pressure fluctuations in the broader population. The study of uncommon Mendelian blood pressure variations, on the other hand, when major blood pressure extremes are caused by mutations in specific genes, has turned out to be quite educational. Gene mutations governing these pathways have been found in families with severe hypotension or hypertension. The autosomal dominant disorder called type II  pseudohypoaldosteronism is characterised by elevated salt reabsorption in the kidneys, hypertension, hyperkalaemia, and excretion of hydrogen and potassium ions. Wilson and associates discovered two genes that cause type II pseudohypoaldosteronism; these genes encode proteins that belong to serine-threonine kinases belonging to the WNK family. Intronic deletions on chromosome 12p are the cause of WNK1 mutations. Additionally, pseudo hypoaldosteronism type II is brought on by missense mutations in chromosome 17's hWNK4(12).

Antioxidant Medicinal Plants

Frequent aerobic metabolic processes, radiation exposure, redox cycling agents, and other environmental factors cause the body to produce radicals that are free. Reactive oxygen species (ROS) are created in vivo by the Oxygen is gradually reduced. These include hydrogen peroxide, superoxide anion, and hydroxyl radical. In addition to other ailments including diabetes and neurological disorders, research has indicated that ROS are important mediators in the development of cardiovascular illnesses. When free radical generation surpasses the antioxidant defence system's capabilities, Oxidative damage is the outcome of oxidative stress to macromolecules such proteins, lipids, and DNA. Glutathione peroxidase, superoxide dismutase, catalase, and decreased glutathione are among the enzymes that make up the human antioxidant defence system. Moreover, exogenous antioxidants such vitamin(1) Foods rich in flavonoids have been thoroughly examined and are known to be potent bioactive substances with a variety of biological effects that impact important signalling pathways of chronic diseases. It is well known that herbal preparations high in flavonoids can help manage metabolic disorders like diabetes mellitus and cardiovasculasr illnesses. It has been discovered that anthocyanins, such as cyanidin and delphinidin 3-glucoside, enhance insulin sensitivity, increase insulin secretion, and facilitate the liver's absorption of glucose in type 2 diabetes. By lowering triglycerides and dangerous fat accumulation, many flavonoids particularly flavanols are recognised for decrease blood pressure and preserve endothelial function Numerous flavonoid compounds have been discovered to offer a wide variety of therapeutic benefits in conditions of the heart, like heart-related disorders, endothelial dysfunction, cardiac fibrosis, myocardial infarction, and ischemic reperfusion injury(2). The body produces free radicals as an effect of regular aerobic metabolism and external influences including radiation and redox cycling materials. As oxygen is gradually reduced in vivo, reactive oxygen species (ROS) such as hydrogen peroxide, superoxide anion, and hydroxyl radical are produced. It has been observed that ROS play a key role as mediators in the emergence of cardiovascular condition as well as other illnesses like diabetes and neurological disorders. Oxidative stress is when the production of free radicals exceeds the antioxidant defence system's capacity, which leads to the progressive oxidation of large compounds like proteins, lipids, and DNA. Enzymes including reduced glutathione, catalase, superoxide dismutase, and glutathione peroxidase are part of the human antioxidant defence system. However, exogenous antioxidants such as ascorbic acid and vitamin E can improve the endogenous antioxidant system's efficacy(4). The ability of medicinal plants to protect against injury to smooth muscle cells in the arteries, endothelial cells, monocytes, cardiomyocytes, and macrophages has been demonstrated. The heart could be impacted by a quantity of chemicals, including diuretics, hypolipidemic, anticoagulants, antioxidants, and anti-inflammatory drugs. For instance, the main way that antioxidants prevent cardiovascular disease is by reducing the body's levels of free radical. Curry leaf is a plant that grows in East Asian countries that are tropical or subtropical, including China, India, Pakistan, and northeastern Australia. It is frequently used as flavouring in Indian cooking, especially in the southern regions. Many of curry leaf's bioactive components have potent antioxidant properties, and the leaf itself has a variety of therapeutic benefits. In diabetic mice, curry leaf is linked to a decrease in harmful LDL cholesterol and a rise in helpful HDL cholesterol, as well as a general decrease in total cholesterol and a drop in blood sugar levels. According to several studies, curry powder's antioxidant qualities reduced the early development of atheroma brought on by the oxidation of LDL cholesterol, implying a potential protection of cardiovascular disease (CVD) (6). Numerous types of medicinal plants, such as those with antiviral, anticancer, heat-clearing, and nourishing and tonic qualities, have had their antioxidant qualities evaluated in the literature (Cai et al., 2004; Chen et al., 2005; Li et al., 2008; Liu et al., 2008). However, the antioxidant qualities of a substantial class of Chinese medicinal herbs that are historically used as herbal tea to prevent and cure cardiovascular and cerebrovascular diseases have not been thoroughly examined (7). An efficient antihyperlipidemic drug is diosgenin. It promotes bone growth by dramatically boosting Type I collagen synthesis and secretion. Diosgenin may lessen the myocardial damage caused by isoproterenol, according to earlier research. By restoring the function of membrane-bound enzymes, its antioxidant qualities helped to maintain electrolyte balance, which may be the mechanism behind its cardioprotective effects(13). Glycyrrhizic acid has antioxidant qualities and protects against isoproterenol-induced cardiac injury, according to in vivo research. Vegetables including tomatoes, red carrots, watermelons, and papayas are rich sources of lycopene, a red carotenoid pigment. According to studies, lycopene is far more powerful than α-tocopherols at scavenging peroxyl radicals and quenching singlet oxygen than other carotenoids. Research has shown that lycopene protects against coronary artery disease, hyperlipidaemia, adrenaline-induced MI, and antioxidant activity(13). Endogenous antioxidant enzyme levels have been linked to cardiovascular disease, according to studies(14,15). In the development of cardiovascular illnesses, elevated ROS generation is frequently linked to increased lipid peroxidation, which damages arterial membranes. Since the production of ROS is essential to heart pathophysiology, treating oxidative stress may greatly improve the treatment of cardiovascular disorders. Additionally, because oxidative stress is a major contributing component, antioxidants may use a radical-scavenging method to reduce cellular damage and apoptosis(16). Myocardial dysfunction, for example, may be lessened by therapeutic strategies that either increase the function of natural antioxidant enzymes or decrease the formation of free radicals. The function of antioxidants in pharmacological studies is being studied in great detail. Because of their many health benefits, antioxidants have gained popularity recently. According to studies, they can lower the risk of heart disease(17). Plants contain chemicals known as antioxidants. Natural antioxidants have recently gained popularity on account of preventing cardiovascular problems such as ischaemia reperfusion (18). Terminalia arjuna a has been implicated in controlling the role of antioxidant enzymes in myocardial infarction caused by isoproterenol, according to studies by Jahan et al.(19). The researchers emphasised the polyphenol-rich T. arjuna extract's cardioprotective benefits in both therapeutic and preventative evaluations. The results show that the degree of isoproterenol-induced myocardial cell death was significant, as seen by the significantly increased levels of blood cardiac marker enzymes such LDH, AST and ALT. Increased lipid peroxidation may cause myocardial cell necrosis; however, the polyphenolic-rich extract's capacity to maintain membrane integrity and restrict enzyme leakage was demonstrated by the drop in serum levels of cardiac marker enzymes following delivery. In addition, T. arjuna therapy restored the magnitudes of myocardial antioxidant enzymes, such as SOD, CAT, and Peroxidase, which had been reduced by isoproterenol induction. When the effects of the plant extracts were compared to the combined effects of the common drugs gemfibrozil and propranolol, they were found to be similar. The extract's antioxidant qualities and polyphenolic components were credited by the researchers with the plant's possible advantages. It has been established that flavonoids have therapeutic potential for cardiovascular disease (CVD). Among the potential processes are their ability to limit platelet aggregation, reduce LDL oxidation, and ameliorate or avoid endothelial dysfunction (20). Studies have looked into Ocimum basilicum's possible heart health advantages. A member of the Lamiaceae family is O. basilicum. Significant terpenoids have been found in the essential oil that was taken from this plant, according to research. According to phytochemical investigations, steroids, polyphenols, and triterpenoids are present. The plant extract has beneficial effects on the changes in blood pressure observed in isoproterenol-induced cardiotoxicity, according to a study by Fathiazad et al.(21). The group's fibrosis and necrosis caused by isoproterenol are inhibited by the plant extract. Isoproterenol-induced myocardial necrosis has an acute phase that is linked to the production of toxic reactive oxygen species. According to reports, the integrity of the cardiac membrane was preserved. This integrity was assessed by measuring the degree of lipid peroxidation, specifically by looking at the concentrations of malondialdehyde (MDA) in serum and myocardial homogenates. The results showed that the extract significantly decreased the MDA levels that were raised by isoproterenol treatment. Ocimum basilicum's cardioprotective effects are ascribed to the flavonoids and phenolics in the plant's antioxidant qualities. These chemicals are found in high concentrations in plants that have the ability to scavenge radicals. The plant has a plasma lipid-lowering effect, which may be important for treating hyperlipidaemia and atherosclerosis, according to previous research by Harnafi et al. (22).

Fig : Mechanism of action of Medicinal Plant as Antioxidant in Cardiovascular Disease

Allium sativum, or garlic, has many health benefits that are associated with its antioxidant properties(23). In a several of models, garlic acid has been displayed to rise the generation of nitric oxide, which helps to avoid endothelial dysfunction(24–26). According to Shackebaei et al(27), garlic juice offers protection during reperfusion. The findings of this investigation demonstrated that garlic juice has an important vasodilatory effect upon the coronary arteries, increasing heart rate in the test group both prior to and throughout reperfusion. By releasing an intracellular enzyme marker, the authors also investigated the extent of reperfusion injury. Indicating considerable defence against malfunction of the endothelium and the inhibition of anaerobic metabolism inside the cardiac muscle cells, the test group was seen to have a lower level of lactate dehydrogenase (LDH) release. In instances of myocardial infarction brought on by isoproterenol, The ability to scavenge free radicals and act as an antioxidant the flavonoids and phenolic compounds found in Evolvulus alsinoides are associated with their cardioprotective advantages (28). The serum and heart tissue of the experimental animals showed near-normal levels of clinical marker enzyme activity, and there was a decrease in the release of enzymes from cardiac cell fractions, indicating a possible membrane stabilising effect (28) In conclusion, the antioxidant properties of flavonoids and phenolics that have been emphasised in a number of studies have helped to stabilise membranes, prevent platelet clumping, restore blood vessel function, lower lipid peroxidation, recover antioxidant enzymes, and suppress reactive oxygen species. Mohanty et al(1). The heart-protective qualities of Ocimum sanctum and Ginkgo biloba have also been mentioned in previous studies. Flavonoids and phenolics antioxidant qualities were connected to the cardioprotective effects of both plants. The study also linked these chemicals to the reduction of lipid peroxidation (29,30), the augmentation of reduced glutathione, and elevated levels of antioxidant enzymes. In rats with isoproterenol-induced myocardial necrosis, Panda and Naik (31) given a combination of Ginkgo biloba and Ocinum sanctum, confirming the heart-protective properties of certain substances that are bioactive found within the two therapeutic plants. This suggests a possible similarity to previously reported mechanisms, even though the combo treatment showed no discernible synergistic effect. Phenolics and flavonoids' strong capacity to scavenge free radicals is associated with their structure-activity connection. Free radicals can be scavenged by flavonoids due to the hydroxyl group's increased reactivity (31)

Anti-inflammatory role

When vascular tissues are exposed to damaging stimuli, inflammation is a complex biological reaction. It has a safeguard function as the body tries to get rid of bad things and start the healing process (32). Cells are activated and inflammatory mediators are released as part of the inflammatory response (33). Chronic heart failure and other cardiovascular disorders have been linked to the activation of inflammation (34,35), and its mediators might serve as important markers of the severity of the disease (36). Inflammatory responses in the artery wall are known to be triggered by markers such as cytokines and interleukins (37). Chemokines and leukocyte adhesion molecules are additional inflammatory agents (38). Leukocyte recruitment, adhesion, rolling, and endothelial cell activation, in addition to platelet adhesion and activation, are all signs of a reaction of inflammation within the microvasculature that can be brought on by risk factors like hypercholesterolaemia (39,40).  This can be avoided by having nitric oxide (NO) in the bloodstream. On the other hand, decreased NO availability results in vascular dysfunction and a decline in endothelial cells' anti-inflammatory capabilities(41). Wallace emphasised during his review the advantages of diets high in naturally occurring bioactive of diets rich in natural bioactive chemicals, particularly their ability to maintain and improve cardiovascular health. He discovered that flavonoids, a kind of polyphenol, are potentially effective preventative measures against cardiovascular disease (CVD) (42). The ability of many medicinal herbs to reduce inflammation has been documented. A review by Kadian and Parle (43) emphasised Ocimum sanctum's anti-inflammatory properties. The pharmacological efficacy of this plant, which has been recognised for its cardioprotective and antihypertensive properties, is ascribed to the suppression of certain inflammatory molecules (44). The linolenic acid found in Ocimum sanctum has anti-inflammatory properties, may be mediated via cyclooxygenase inhibition and lipoxygenase routes that are involved in the metabolism of arachidonate, according to Singh and Majumdar (45). The cyclooxygenase (COX) and lipoxygenase (LOX) enzymes are necessary for the production of lipid mediators from arachidonic acid, which are important in inflammation. According to Xing et al. (46), ginsenosides are triterpene saponins of the dammarane class that have anti-inflammatory qualities. Ophiopogonis Radix (the root of Ophiopogon japonicus (L.f) Ker-Gawl), Ginseng Radix Et Rhizoma Rubra (the root of Panax ginseng C.A. Mey.), and Schisandrae Chinensis Fructus (the fruit of Schisandra chinensis (Turcz.) Baill) were found to be able to lower the expression of inflammatory mediators. According to the study, one important bioactive ingredient that contributed to the noted anti-inflammatory benefits was ginsenosides. Blood artery dilatation, lipid peroxidation decrease, myocardial contractility, and anti-inflammatory properties were all found to be significantly enhanced by the three herbs in YQFM (47–50). A common contributing element to many illnesses, particularly cardiovascular diseases (CVDs), is inflammation. Although it hasn't been proven beyond a reasonable doubt that inflammation causes heart disease, those with CVD are known to have higher levels of inflammation. There is a clear correlation between increased inflammation and the risk of cardiovascular illnesses, according to a number of epidemiological and clinical research (51). Patients with CVD have been found to exhibit a range of inflammatory markers, elevated C-reactive protein sensitivity (CRP) being the most readily available and inflammatory marker with clinical reliability. 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, another name for statins, are among the medications that have been found to reduce inflammation associated with cardiovascular disease (CVD) (52). Whether reducing C-reactive protein (CRP) actually lowers cardiovascular risk is unknown, though. Therefore, the need for safe and efficient medicines that can lower the risk of CVD is urgent. CVD may be less common and its risk factors may be reduced by the Lamiaceae family. It has been discovered that the aqueous extract of Ajuga iva, among other plants, has vasorelaxant properties in vitro. Nitric oxide (NO) modulation appears to have an impact on the vasorelaxation brought on by the Ajuga iva extract. NO plays a role in regulating the functional activity of macrophages and other inflammatory cell types. The inflammatory phospholipid mediator platelet-activating factor (PAF) has been demonstrated to be inhibited by derivatives of Lavandula angustifolia essential oils. This PAF suppression shields the heart muscle from metaproterenol induced myocardial infarction in rats (53). The ethyl acetate excerpt from L. Anguistifolia also inhibits iNOS/NO signalling, cyclooxygenase (COX)-2 gene expression, and IL1β, thereby reducing Inflammation caused by lipopolysaccharide (LPS) in RAW264.7 macrophages(54). Therefore, reducing CVD is aided by these plants' anti-inflammatory properties. Research has looked into Leonurus cardiac ability to fortify cardiac muscle, which could lower the risk of CVD (55). Extracts high in polyphenols from this plant are known to lower inflammation by preventing the release of PAF caused by staphylococcal peptidoglycan, even though the precise mechanism underlying muscular strengthening is unknown (56). Marrubium vulgare methanol extract has shown protective benefits against isoproterenol-induced acute myocardial infarction when given at 10, 20, and 40 mg/kg dosages (57). Furthermore, it has been demonstrated that an aqueous fraction of M. vulgare at a concentration of 40 μg/mL lessens Perfusion-ischemia (I/R) injury in rats (58). According to the findings, M. vulgare has heart-protective qualities. Because it prevents chemical that causes inflammation COX-2, it is possible that this property could be connected to its capacity to lower inflammation, even though the precise mechanism underlying its cardioprotective properties is still unknown. Used all over the world, Mentha arvensis has been shown to improve heart health by lowering inflammation. Significant reduction of IL-8 secretion in AGS cells was seen by an extract from this plant at a level of 100μg/ml, which may be related to cardiovascular disorders (CVD) (59). Additionally, M. piperita, another species of Mentha, has the ability to lower inflammation, both acute and long-term(60). Reduced levels Comprising fibroblast growth factor-2 (FGF-2), vascular endothelial growth factor (VEGF), and tumour necrosis element-alpha (TNF-α) are associated with the anti-inflammatory effects (61). A reduction in CVD may be linked to M. piperita anti-inflammatory properties because those with CVD typically have higher levels of inflammation.  M. modarresi also has cardioprotective properties (62)RAW 264.7 in mouse macrophages, M. pulegium greatly reduced the release of IL-6, MCP-1, and TNF-α, proving its anti-inflammatory qualities (63). The idea that Lamiaceae can function as potent cardioprotective and anti-inflammatory medicines is supported by these studies.

Traditional medicine in several African countries has used Melissa officinalis as a calming agent, an antispasmodic, and for its cardioprotective qualities. This plant's essential oil showed anti-inflammatory qualities in tests Employing carrageenan and rats with injury to the hind paw oedema (64). Additionally, in rats, extracts from M. officinalis have demonstrated protective advantages against deadly ventricular arrhythmias brought on by reperfusion. Additionally, M. officinalis leaf lyophilised aqueous extract can be utilised to treat benign palpitations, which are a common problem that cause a lot of distress and make treatment more difficult. In a study, the frequency of heart palpitations decreased in healthy individuals who received 500 mg of freeze-dried M. officinalis leaf aqueous extract twice day for 14 days (or a placebo) (65). In a different randomised, double-blind clinical study, M. officinalis showed cardioprotective qualities through enhancing lipid levels, controlling blood sugar, and reducing inflammation (66). Additionally, Ocimum species extracts have a major impact on cardiac functioning. When rats were given isoproterenol, the ethanolic extract of the aerial portions of O. basilicum and O. sanctum prevented myocardial infarction (67)(68). The ability of Ocimum species to lower inflammation may be related to their cardioprotective qualities. Rat paw oedema caused by carrageenan and other inflammation mediators was shown to be alleviated by the essential oil of O. basilicum. Additionally, it prevented rats' metabolism of arachidonate, a major inflammatory mediator (69). In rats that had myocardial infarction brought on by isoproterenol, it was also discovered that the methanol extract from O. sanctum leaves decreased inflammation. 5-lipoxygenase, COX-2, leukotriene B4, and thromboxane B2 levels that were raised by isoproterenol were all reduced in rats that received this extract prior to treatment (70). Heart troubles are among the many health conditions that Origanum majorana has historically been used to treat. In rats that had myocardial infarction caused by isoproterenol, both powdered and aqueous extracts of sweet marjoram leaves increased corresponding weight of the heart, reduced the oxidative stress of the heart, and prevented the release of heart enzymes like aminotransferase, lactate dehydrogenase, and creatine phosphokinase(71). LPS-treated murine macrophage RAW264.7 cells showed an anti-inflammatory response to essential oil (EO) extracted from oregano leaves in in vitro tests. Additionally, this EO decreased the release and synthesis of TNF-α, IL-6, and interleukin (IL)-1β in RAW264.7 cells exposed to LPS (72). Oregano (Origanum vulgare) ethanol extract, in addition to its essential oil, also reduced inflammation caused by Propionibacterium acnes both in vitro and in vivo (73). Therefore, it is possible that the anti-inflammatory qualities of Origanum species Participate in their cardioprotective effects. Its potential for anti-inflammatory activities is shown by the fact that has been demonstrated that Plectranthus barbatus extract lowers the synthesis of pro-inflammatory cytokines. (74). Plectranthus species have also been shown to have anti-inflammatory qualities. Plectranthus amboinicus decreased the rise in the pro-inflammatory cytokines TNF-α and IL-8 in the blood in a model of rats that was generated by LPS (75). Activated human neutrophils' 5-lipoxygenase activity was markedly suppressed by Plectranthus zeylanicus extracts made with n-hexane or dichloromethane (76). The anti-inflammatory properties of Plectranthus species may aid in cardio protection, even if their cardioprotective advantages have not been well studied. Rosemary leaves are used to cure a variety of illnesses and have been shown in experiments to have anti-inflammatory qualities. By improving energy metabolism in a rat model, rosemary supplementation helped to decrease cardiac remodelling. When this supplement was taken after a myocardial infarction, diastolic function improved and hypertrophy decreased (77). An active ingredient found naturally in Leonurus cardiac, leu urine has demonstrated that provide a range of biological benefits, like as protection against cardiovascular diseases (CVDs). This substance acts as a supporting agent for heart protection and has been shown to lessen myocardial damage because of its antioxidant and anti-apoptotic characteristics. Leon urine also enhances anti-apoptotic gene expression Bcl-2 and suppresses the production of the pro-apoptotic protein Bax, which helps prevent acute myocardial ischaemia(78)(79). Apigenin, found in both L. cardiac and Apium graveolens, has shown similar methods of heart protection. By raising the protein Bcl-2 levels, lowering the expression of the Bax protein, and decreasing caspase-3 activity, it reduces cardiomyocyte apoptosis. Additionally, during cardiac ischemia/reperfusion (I/R), apigenin prevents p38 MAPKs from becoming phosphorylated. Leonurine inhibits cardiac cell death inside H9c2 cardiac cells by upregulating Akt phosphorylation, hypoxia inducible factor-1α (HIF-1α) expression, survivin, and VEGF (78).
Leonurine has also been demonstrated to lessen myocardial infarctions' severity and collagen deposition, prevent cell death, and enhance function of the heart. These consequences of leonurine were demonstrated to be handled by lower amounts of caspase3, cleaved-caspase3, and Bax, as well as elevated levels of Bcl-2, p-AKT, p-GSK3β, and phosphorylated (p)-PI3K. Thus, by triggering the activating PI3K/AKT/GSK3β signalling pathway, leonurine has strong cardioprotective and anti-apoptotic consequences (80).
Rosmarinic acid has important cardioprotective qualities because it can increase the  antioxidant enzymes action and stimulate the way genes are expressed for rasoplasmic reticulum Ca2+ ATPase 2 (SERCA2) and ryanodine receptor-2 (RyR2), both of which are essential for preserving Ca2+ balance (81). Rosmarinic acid protects the heart from fibrosis by activating AMPKα, reducing phosphorylation, and moving Smad3 to the nucleus, according to a new study. To lessen cardiac fibrosis, this substance also stimulates peroxisome proliferator-activated receptors (PPAR-γ) (82).

The activation of PPAR-γ also contributes to the cardioprotective effects of Apigenin, since its antagonist counteracted Apigenin's myocardial protective effects (83). Further studies showed that Apigenin reduced the cardiotoxicity caused by Adriamycin in mice and activated the Akt/PI3K/mTOR pathway (84)In vitro and in vivo, quercetin, a substance present in a number of plants in the Lamiaceae family, demonstrates notable cardioprotective effects. NF-κb, AP-1, and MMP-9 are among the inflammatory molecules whose expression is decreased by it (85). Quercetin also has cardioprotective qualities by inhibiting the actions of MAPK, JNK, and focal adhesion kinase in endothelial cells that are activated by thrombin (86). By increasing ATP levels, boosting antioxidant enzymes like GSH, and lowering elevated levels of cardiac TBARS, plasma creatine kinase, and NO(x), additionally, it has been discovered to as a cardioprotective substance (87,88). A naturally occurring bioactive substance, carvacrol, has cardioprotective qualities via a number of methods. By reducing the extent of the infarct and the levels of cardiac enzymes including cardiac troponin T, creatine kinase, and lactate dehydrogenase, studies have shown that it can reduce myocardial ischaemic damage in an acute myocardial infarction model in rats. It has also been discovered that carvacrol raises the activity of antioxidant enzymes such as glutathione, superoxide dismutase, and glutathione peroxidase while lowering malondialdehyde levels. Moreover, carvacrol has been demonstrated to upregulate the protein expression of Bcl-2 while simultaneously suppressing the activation of caspase-3 and BAX expression (89). Carvacrol showed anti-apoptotic qualities against rats cardiac I/R damage and raised the levels phosphorylated ERK, according to another study. Carvacrol also encouraged the Akt/eNOS pathway to be activated in cardiomyocytes, which led to cardio protection. Thus, carvacrol's cardioprotective advantages, linked to its anti-apoptotic and antioxidant properties, are mediated by MAPK/ERK and Akt/eNOS signalling pathways (90). One of Thymus species' main active compounds, thymoquinone, has been identified as potentially beneficial for cardiovascular health. Thymoquinone has been shown in a recent study to decrease the size of the infarct and enhance heart function. Rats suffering from cardiac ischemia/reperfusion damage, Thymoquinone's cardioprotective mechanism was associated with decreased cardiac levels of Lactate dehydrogenase, creatine kinase, and apoptosis inhibition (91).  According to research, it possesses antioxidative qualities by increasing the superoxide dismutase's function and reducing the production of malondialdehyde and hydrogen peroxide. Additionally, Thymoquinone increased SIRT1 expression and inhibited p53 acetylation, providing protection against heart injury(92). Scutellaria baicalensis, Scutellaria lateriflora, and other plants in the Lamiaceae family are the source of baicalein, an active chemical that exhibits heart-protective properties via a variety of molecular pathways. Apart from its anti-inflammatory qualities, it also has antioxidant capabilities. It has been demonstrated to lower MDA levels while increasing SOD and GSH-Px activity(93,94). It also prevents the NF-κB and MAPK pathways from being activated in rats. Additionally, this chemical showed the capacity to protect cardiomyocytes from cell oxidative stress-induced harm via the Nrf2/Keap1 pathway (95). The phosphorylation of Ca2+/calmodulin-dependent protein kinase II (CaMKII) and the expression of Na+/Ca2+-exchangers (NCX1) are also decreased by baicalein, although SERCA2 and RYR2 are increased (96).

 

Fig : Mechanism of action of Medicinal Plant as Anti-inflammatory in a Cardiovascular Disease

Table 1: Traditional and Modern Applications of Medicinal Plants in Cardiovascular Disease Treatment

Medicinal plants

Activities

Reference

Vernalis Adonis

 

We evaluated the efficacy of Adonis vernalis tincture as a hypotensive remedy. Dogs' blood pressure responses differed according to

dosage; greater dosages caused blood pressure to drop, while lower doses caused blood pressure to rise

(97)

Eupatoria agrimonia

 

Anaesthetized cats given agrimony extracts intravenously have been found to experience a hypotensive response, with blood pressure dropping by more than 40%.

(98)

Allium sativum

 

Clinical testing and research have shown that garlic lowers blood pressure. Garlic significantly reduced blood pressure, both diastolic and systolic.

(99–101)

Rosea Althaea

Cats under anaesthesia showed a brief drop in blood pressure when given the alcoholic extract.

(102)

Visnaga Ammi

 

Overall, vascular smooth muscle activity was inhibited by visnadine. In particular, it decreased the contractile reaction in isolated rat aortic rings and portal vein segments. Visnagin, on the other hand, reduced blood pressure when administered intravenously without significantly changing heart rate.

(103–105)

Anethum graveolens

When cats were given intravenous 5% seed oil in 5–10 mg of saline per kilogramme of body weight, their blood pressure decreased and their respiratory capacity increased.

(106)

Crista caesalpinia

 

When a water-based leaf extract was administered, blood pressure gradually decreased. The extract's ability to reduce blood pressure was reversible and dosage dependent. The aqueous leaf extract of Caesalpinia crista or cholinergic induced hypotension, which atropine prevented.

(107)

Cicer arietinum

The hydrolysate created by treating Cicer arietinum legumin with alcalase has an IC50 of 0.18 mg/ml and inhibited the angiotensin I converting enzyme. This hydrolysate was separated using rear phase chromatography, which produced IC50 values for six inhibitory peptides range from 0.011 to 0.021 mg/ml.

All of these peptides contain the amino acid methionine in addition to a large number of other hydrophobic amino acids. Alkalase treated chickpea legumin hydrolysates are a rich source of peptides that have the capacity to stop the angiotensin-converting enzyme from working.

(107,108)

Cordia myxa

 

Young, ripe Cordia obliqua gum When rabbits were hypotensive, rco and urco lowered blood pressure and accelerated breathing. Compared to Rco, Urco was 1237 times more effective. The hypotensive effect is most likely brought on by the addition of vasodilatation and the activation of the parasympathetic ganglia, according to an analysis of the mechanism of action.

(109,110)

Sativum Coriandrum

 

The crude extract of coriander (1–30 mg/ml) reduced the arterial blood pressure reading of anaesthetised creatures whose atropine blockage was not complete. A crude extract of coriander generated vasodilatation in rabbit aortas against the effects of K (80 mM) and phenylephrine condensation, and it had a cardio-depressant effect on guinea-gormandizer gallerias. The waterless and organic fragments' spasmogenic and spasmolytic components were found to be separated independently by bioassay-directed separation. Similarly, a crude extract of coriander caused diuresis in rats at 1–10 mg/kg dosages.

(111,112)

Crocus sativus

The impact of Crocus sativus on Ca2 abundance in insulated rat aortas was investigated using 45Ca, a radioactive dick. Crocus significantly decreased the attention-dependent Ca2 fluxes brought on by KCL (100 mmol/l) and norepinephrine (1.2 mmol/l); however, under normal physiological conditions, these medications had no appreciable impact on the absorption of Ca2 in insulated rat aorta rings. The results showed that through receptor-operated and implicitly dependent Ca2 channels, crocus can reduce extracellular Ca2 abundance.

(113)

Daucus carota

When given an ethanolic extract of Daucus carota at doses of 10–100 mg/kg, rats under normotensive anaesthesia demonstrated a cure-dependent drop in systolic and diastolic arterial blood pressure. These products were not blocked by one mg of atropine per kilogramme. Pretreatment with Daucus carota did not alter the pressor response to norepinephrine, suggesting that the plant's cardiovascular advantages were independent of cholinergic or adrenergic receptor activation. In guinea-gormandizer paired gallerias that were beating spontaneously, Daucus carota persuaded a force and rate of atrial condensation to decrease in an attention-dependent manner (0.3–5 mg/ml). At comparable attention, Daucus carota inhibited K-confirmed condensation in the rabbit thoracic aorta.

(114,115)

Adonisa estivalis

One of the many cardenolides that were removed from Adonisa estivalis is stronthidin aglycone. These composites' direct impact, which is caused by suppression of the enzyme system pump for sodium potassium adenosine triphosphatase, is comparable to that of other cardiac glycoside-containing stores. By raising vagal tone, they slow down the rate at which the sinoatrial knot depolarises. Ventricular arrhythmias, ventricular fibrillation, bradycardia, and various forms of atrioventricular block are among the electrocardiographic abnormalities observed with intoxication.

(116,117)

 

Alhagi maurorum

Rats under anaesthesia were used to test the effects of an ethanolic extract of ground Alhagi maurorum roots. The findings showed that at a dose of 1 g/kg, the extract only produced bradycardia and not cardiac depression.
On an insulated rat heart, the novel aliphatic ester glyceryl n-tetracosan-17-ol-1 oats demonstrated both a myocardial depressive and a heart rate goading action.

(118,119)

Althaea rosea

Alcoholic extract from Althaea rosea L. flowers significantly widened the blood vessels in the rats' hind branches and raised the evacuation of the coronary highway in the insulated guinea gormandizer's heart. On anaesthetic pussycats, the snippet had a flash hypotensive effect. It demonstrated a suppressive impact on the experimental thrombosis conformation and prevented platelet aggregation propelled by ADP.

(120)

Ammi visnaga

In many animal species, Ammi Visnaga shown that smooth muscle relaxation, including that of the coronary highways, is possible. The heart benefited from the inotropic effects of samidin and cholel glucoside. 38 instances of angina pectoris and 8 cases of coronary thrombosis were included in a clinical trial using khellin. Continuous treatment of angina pectoris, whether oral, intramuscular, or both, was beneficial in 35 out of 38 instances. It was beneficial to provide khellin continuously for a few weeks to eight instances following coronary thrombosis.

(121,122)

Anchusa strigosa

The excerpt had no effect on the dog's ventricular compression, but it was intended to have a minor inhibitory effect on the aural compression in bilaterally vagotomized dogs. These findings suggest that the point of action is most likely a blood artery.

(123,124)

Apium graveolens

A negative chronotropic and inotropic conduct is displayed by both waterless and ethanol extracts.
The breadth decreased by ± 0.89 and the rate of condensation by 12.88 ± 2.74 in the waterless extract. The gallerias condensation rate was decreased by 34.26 ± 5.69 and the breadth by 25.40 ± 3.61 by the ethanol extract.

(125)

Bacopa monnieri

An ethanolic extract of the whole Bacopa monnieri factory has demonstrated cardiac lowering effects on heart rate, coronary inflow, and left ventricular contractility in an insulated rabbit heart.
Furthermore, it seemed that the ethanolic extract of Bacopa monnieri made an effort comparable to that of a quinidineon heart.

(126)

Brassica nigra

Mustard increased respiratory and heart effort to the point where it may wake someone up from a conking attack. Its automatic effect on the heart and respiratory centre promotes rotation and breathing.

(127,128)

Calendula officinalis

Rats that received a 50 mM infusion of calendula in KHB buffer for 15 minutes before ischaemia showed cardio protection by boosting aortic inflow and left ventricular advanced pressure, while also reducing the amount of myocardial infarcts and cardiomyocyte apoptosis. The lowering of TNFα and the activation of Akt and Bcl2 imply that cardio protection is achieved by altering anti-inflammatory and antioxidant pathways, which turns the ischaemia reversed.

(129)

Calotropis procera

It was estimated that latex protected albino rats from myocardial infarction caused by isoproterenol (20 mg/100g). The pretreatment, which involved taking an ethanolic latex extract 30 days at a dose of 300 mg/kg body weight, three times daily, was significantly reduced.

(130)

Carthamus tinctorius

Adult rats with left anterior descending coronary artery ligation showed myocardial ischaemia injury in a beast model.
Pretreatment with C. tinctorius (ECT) at doses of 100, 400, and 600 mg/kg body weight protected the heart from ischaemia injury by reducing the size of infarcts and enhancing cardiac function.
In an in vitro experiment, the direct cytoprotective effect of ECT against H2O2 exposure was evaluated using neonatal rat ventricular myocytes. Cell viability was markedly enhanced by a pretreatment with 100–400 microg/ml ECT prior to exposure to H2O2. ECT also significantly reduced the mortality of cardiomyocytes caused by H2O2.

(131,132)

Cheiranthus cheiri

Two olitorisides, erysimoside, and cardiac glycosides known as cheiranthosides I–XI were separated from the factory seeds. The glycosides' inhibitory effect on Na, K-ATPase was calculated by contrasting them with other common cardiac glycosides. The high inhibiting exertion of digitoxin was exhibited by two of them, cheiranthoside III and VIII. Cheiranthoside XI, which had a carboxyl group and a rhamnopyranosyl digitoxopyranosyl half, shown the least amount of exertion, comparable to that of the inactive aglycone strophanthidin.

(133)

Corchorus aestuans

The isolated frog heart perfusion method (IFHP) was used to assess cardiac glycoside for cardiotonic exertion after it had been isolated from the factory fruits.
At lower dosages (0.4 mg), there was a discernible drop in heart rate (negative chronotropic effect) and an increase in compression force height (positive inotropic impact). Therefore, a large remedial indicator was shown by the examined cardiac glycoside in comparison to the standard.

(134,135)

Corchorus capsularis

Insulated from Corchorus capsularis seeds, the cardiac aglycone corchortoxin (strophanthidin) showed a cardio-alcoholic exertion. The digitalis rubric was similar to these conditioning methods.
However, compared to corchortoxin, an extract from jute seeds demonstrated superior conditioning. Digitalis-like behaviour was also seen in Corchorosides A and B, which were also isolated from other stores.

(136–138)

Coronilla varia

The effects and toxins of digoxin and ouabain were two cardiac glycosides' cardiotonic and cardiotoxic properties that were separated from Coronilla variety seeds: hyrcanoside and deglucohyrcanoside. The cardiotonic impact was evaluated using the isolated heart (Langendorff) and the heart in situ. The findings demonstrated that deglucohyrcanoside outperformed hyrcanoside and that its effects were similar to those of digoxin and ouabain. Deglucohyrcanoside's efficacy was at least as high as digoxin's, but Its toxicity was significantly reduced, indicating that the glycoside was a likely candidate for use in medicine.

(139–141)

Erodium cicutarium

The addition of Erodium cicutarium extracts to the Kreb's result perfusing insulated rabbit heart resulted in a negative ionotropic effect. Hexane and methanol, which are organic extracts, exert less force on the heart and smooth muscles than water extracts.

(142,143)

Achillea santolina

In order to ascertain the impact of Achillea santolina's methanolic extract on the electrophysiological parcels, Rats' insulated hearts served as the paradigm for the experiment. The findings indicated that the time constant of recovery increased non-significantly and a significant depression of WBCL, AVCT, and ERP. It might be regarded as an implicit medication with anti-arrhythmic effects for treating supraventricular tachyarrhythmia or suppression.

(144)

Cichorium intybus

Eight different species of Cichorium intybus were studied pharmacologically on the heart of an insulated toad. The results indicated that each species acted similarly to quinidine but with varying energy.

(145)

CONCLUSION

Chronic inflammation and oxidative stress are key contributors to the progression of cardiovascular diseases (CVD), including myocardial infarction, hypertension, and atherosclerosis. Medicinal plants rich in bioactive compounds such as flavonoids, phenolics, and other phytochemicals offer significant cardioprotective benefits by modulating inflammatory pathways, reducing oxidative damage, and enhancing endothelial function. The therapeutic potential of these natural agents highlights their role in cardiovascular risk reduction. This review underscores the promising application of antioxidant and anti-inflammatory medicinal plants in CVD treatment, paving the way for further research and potential integration into cardiovascular healthcare strategies.

List of Abbreviation

CVD  -  Cardiovascular Disease

CHD   -   Coronary Heart Disease 

CTnl   -   Cardiac Troponin I

ROS  -   Reactive Oxygen Species

DNA  -  Deoxyribonucleic Acid

HDL  -  High Density Lipoprotein

LDL  -  Low Density Lipoprotein

MI  -  myocardial Infraction

LDH  -  Lactate Dehydrogenase

AST  -  Aspartate Aminotransferase

ALT  -  Alanine Transaminase

SOD  -  Superoxide Dismutase

CAT  -  Calcified Amorphous Tumors

CVD  -  Cardiovascular Disease

MDA   -  Malondialdehyde

NO  -  Nitric Oxide

COX  -  Cyclooxygenase

LOX  -  Lipoxygenase

CRP  -  C-reactive Protein Sensitivity

HMG – COA  -  Hydroxymethylglutaryl-CoA

PAF  -  Platelet-Activating Factor

iNOS/NO  -  Inducible Nitric Oxide Synthase and Nitric Oxide

LPS  -  Lipopolysaccharide

IL  -  Interleukin 

AGS  -  Human Gastric Adenocarcinoma

FGF  -  Fibroblast Growth Factor

VEGF  -  Vascular Endothelial Growth Factor

MCP  -  Monocyte Chemoattractant Protein

TNF  -  Tumour Necrosis Factor

LPS  -  Lock-Step Phenomenon

EO  -  Essential Oil

BCL 2  -  B-cell lymphoma 2

SERCA -  Sarcoendoplasmic Reticulum Calcium ATPase

RyR2  -  Ryanodine Receptor 2

PPAR-Y  -  Peroxisome Proliferator-Activated Receptor Gamma

BAX  -  Bcl-2-Associated Protein X 

Akt/eNOS   -  Ak Strain Transforming / Endothelial Nitric Oxide (NO) Synthase

Ca  -  Calcium

KCL  -  Potassium chloride

Akt   -  Ak Strain Transforming

ECT  -  Electroconvulsive therapy.

REFERENCES

        1. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Review Article Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review [Internet]. Vol. 7, Am J Cardiovasc Dis. 2017. Available from: www.AJCD.us/
        2. Khan J, Deb PK, Priya S, Medina KD, Devi R, Walode SG, et al. Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Vol. 26, Molecules. MDPI AG; 2021.
        3. Griffiths K, Aggarwal B, Singh R, Buttar H, Wilson D, De Meester F. Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases. 2016 Aug 1;4(3):28.
        4. Ashish Tilak-Jain J, Paul Asir Devasagayam T. Cardioprotective and Other Beneficial Effects of Some Indian Medicinal Plants. Vol. 38, J. Clin. Biochem. Nutr. 2006.
        5. and Alternative Medicine EBC. Retracted: Prevention and Treatment of Cardiovascular Diseases with Plant Phytochemicals: A Review. Evidence-Based Complementary and Alternative Medicine. 2023 Jan;2023(1).
        6. Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies. Recent Pat Inflamm Allergy Drug Discov. 2018 Aug 30;12(2):145–57.
        7. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine (CCLM). 2020 Jun 25;58(7):1131–4.
        8. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020 May 11;109(5):531–8.
        9. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar;395(10229):1054–62.
        10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb;395(10223):497–506.
        11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061.
        12. Nabel EG. Cardiovascular Disease. New England Journal of Medicine. 2003 Jul 3;349(1):60–72.
        13. G N, SANDUR V R. CARDIOPROTECTIVE POTENTIAL OF PLANTS AND PLANT-DERIVED PRINCIPLES – A REVIEW. Asian Journal of Pharmaceutical and Clinical Research. 2019 Feb 15;46–56.
        14. Ojha S, Bharti S, Sharma AK, Rani N, Bhatia J, Kumari S, et al. Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction. Indian J Biochem Biophys. 2011 Feb;48(1):22–8.
        15. Kumar AH, Javed A, Jaiswal M, Talkad MS. Cardioprotective Effects in Methanolic Extract of Evolvulus Alsinoides Linn on Isoproterenol-Induced Myocardial Infarction in Albino Rats [Internet]. Vol. 2, International Journal of Basic Medical Sciences and Pharmacy (IJBMSP). 2012. Available from: www.sciacademypublisher.com53
        16. Angeloni C, Spencer JPE, Leoncini E, Biagi PL, Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie. 2007 Jan;89(1):73–82.
        17. Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004 Oct;52:794–804.
        18. You J, Pan T, Lee Y. Protective effects of Danshen ( Salvia Miltiorrhiza ) on adriamycin?induced cardiac and hepatic toxicity in rats. Phytotherapy Research. 2007 Dec 18;21(12):1146–52.
        19. Jahan N, And KUR, Ali S. Cardioprotective and Antilipidemic Potential of Cyperus rotundus in Chemically Induced Cardiotoxicity. Int J Agric Biol [Internet]. 2012; Available from: http://www.fspublishers.org
        20. Keevil JG, Osman HE, Reed JD, Folts JD. Grape Juice, But Not Orange Juice or Grapefruit Juice, Inhibits Human Platelet Aggregation. J Nutr. 2000 Jan;130(1):53–6.
        21. Fathiazad F, Matlobi A, Khorrami A, Hamedeyazdan S, Soraya H, Hammami M, et al. Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats. DARU Journal of Pharmaceutical Sciences. 2012 Dec 5;20(1):87.
        22. Harnafi H, Serghini Caid H, el Houda Bouanani N, Aziz M, Amrani S. Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in Triton WR-1339-induced hyperlipidemic mice. Food Chem. 2008 May;108(1):205–12.
        23. Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: the good, the bad and the ugly. Phytotherapy Research. 2003 Feb 10;17(2):97–106.
        24. Maslin DJ, Brown CA, Das I, Zhang XH. Nitric oxide - a mediator of the effects of garlic? Biochem Soc Trans. 1997 Aug 1;25(3):408S-408S.
        25. SOORANNA SR, HIRANI J, DAS I. Garlic can induce both GTP cyclohydrolase and nitric oxide synthase activity in choriocarcinoma cells. Biochem Soc Trans. 1995 Nov 1;23(4):543S-543S.
        26. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis. 2017;7(2):19–32.
        27. Shackebaei D, Godini A, Pilehvarian A. Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion. 2010.
        28. Kumar AH, Javed A, Jaiswal M, Talkad MS. Cardioprotective Effects in Methanolic Extract of Evolvulus Alsinoides Linn on Isoproterenol-Induced Myocardial Infarction in Albino Rats [Internet]. Vol. 2, International Journal of Basic Medical Sciences and Pharmacy (IJBMSP). 2012. Available from: www.sciacademypublisher.com53
        29. Naik SR, Pilgaonkar VW, Panda VS. Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain. Phytotherapy Research. 2006 Nov 14;20(11):1013–6.
        30. Uma Devi P, Ganasoundari A, Vrinda B, Srinivasan KK, Unnikrishnan MK. Radiation protection by the ocimum flavonoids orientin and vicenin: mechanisms of action. Radiat Res. 2000 Oct;154(4):455–60.
        31. Panda VS, N SR. Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents. Altern Med Rev. 2009 Jun;14(2):161–71.
        32. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 2007 Feb;147(2):227–35.
        33. Anosike CA, Obidoa O, Ezeanyika LU. Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (Solanum aethiopicum). Daru. 2012 Nov 14;20(1):76.
        34. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003 Feb 6;91(3A):3A-6A.
        35. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 Feb;11(2):119–29.
        36. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul;15(4):331–41.
        37. Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. Vol. 38, Journal of Ginseng Research. Elsevier B.V.; 2014. p. 161–6.
        38. Candia AM de, Villacorta H, Mesquita ET. Immune-inflammatory activation in heart failure. Arq Bras Cardiol. 2007 Sep;89(3):183–90, 201–8.
        39. Scalia R, Appel JZ, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1093–100.
        40. Stokes KY, Calahan L, Russell JM, Gurwara S, Granger DN. Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation. 2006;13(5):377–88.
        41. Stapleton PA, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond). 2010 Nov 18;7:54.
        42. Wallace TC. Anthocyanins in cardiovascular disease. Adv Nutr. 2011 Jan;2(1):1–7.
        43. Kadian R, Parle M. INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Therapeutic potential and phytopharmacology of tulsi. Int J of Pharm & Life Sci (IJPLS). 2012;3(7):1858–67.
        44. Ahlawat B, Om D, Sharma P, Scholar PG. PHARMACOLOGICAL ACTIVITIES OF OCIMUM SANCTUM (TULSI): A REVIEW [Internet]. Available from: www.wjpmr.com
        45. Singh S, Majumdar DK. Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil. Indian J Exp Biol. 1997 Apr;35(4):380–3.
        46. Xing L, Jiang M, Dong L, Gao J, Hou Y, Bai G, et al. Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression. J Ethnopharmacol. 2013 Jun 21;148(1):239–45.
        47. Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu B, et al. Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol Pharm Bull. 2005 Jul;28(7):1234–8.
        48. Lee DCW, Lau ASY. Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review. Molecules. 2011 Mar 30;16(4):2802–16.
        49. Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009 Jul;7(3):293–302.
        50. Oh SY, Kim YH, Bae DS, Um BH, Pan CH, Kim CY, et al. Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci Biotechnol Biochem. 2010;74(2):285–91.
        51. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10.
        52. Yeh ETH, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003 Jan 28;107(3):370–1.
        53. Ziaee M, Khorrami A, Ebrahimi M, Nourafcan H, Amiraslanzadeh M, Rameshrad M, et al. Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat. Iran J Pharm Res. 2015;14(1):279–89.
        54. Kulabas SS, Ipek H, Tufekci AR, Arslan S, Demirtas I, Ekren R, et al. Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. J Ethnopharmacol. 2018 Sep 15;223:88–98.
        55. Wojtyniak K, Szyma?ski M, Mat?awska I. Leonurus cardiaca L. (Motherwort): A Review of its Phytochemistry and Pharmacology. Phytotherapy Research. 2013 Aug 8;27(8):1115–20.
        56. Sadowska B, Micota B, Ró?alski M, Redzynia M, Ró?alski M. The immunomodulatory potential of Leonurus cardiaca extract in relation to endothelial cells and platelets. Innate Immun. 2017 Apr 31;23(3):285–95.
        57. Yousefi K, Soraya H, Fathiazad F, Khorrami A, Hamedeyazdan S, Maleki-Dizaji N, et al. Cardioprotective effect of methanolic extract of Marrubium vulgare L. on isoproterenol-induced acute myocardial infarction in rats. Indian J Exp Biol. 2013 Aug;51(8):653–60.
        58. Garjani A, Tila D, Hamedeyazdan S, Vaez H, Rameshrad M, Pashaii M, et al. An investigation on cardioprotective potential of Marrubium vulgare aqueous fraction against ischaemia-reperfusion injury in isolated rat heart. Folia Morphol (Warsz). 2017 Sep 7;76(3):361–71.
        59. Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilani AH, Jafri W, et al. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J Ethnopharmacol. 2012 May;141(1):403–10.
        60. Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998 Mar;60(2):117–24.
        61. Modarresi M, Farahpour MR, Baradaran B. Topical application of Mentha piperita essential oil accelerates wound healing in infected mice model. Inflammopharmacology. 2019 Jun 6;27(3):531–7.
        62. Mani Badal R, Badal D, Badal P, Khare A, Shrivastava J, Kumar V. Pharmacological Action of Mentha piperita on Lipid Profile in Fructose-Fed Rats. Iran J Pharm Res. 2011;10(4):843–8.
        63. Brahmi F, Nury T, Debbabi M, Hadj-Ahmed S, Zarrouk A, Prost M, et al. Evaluation of Antioxidant, Anti-Inflammatory and Cytoprotective Properties of Ethanolic Mint Extracts from Algeria on 7-Ketocholesterol-Treated Murine RAW 264.7 Macrophages. Antioxidants. 2018 Dec 6;7(12):184.
        64. Bounihi A, Hajjaj G, Alnamer R, Cherrah Y, Zellou A. In Vivo Potential Anti-Inflammatory Activity of Melissa officinalis L. Essential Oil. Adv Pharmacol Sci. 2013;2013:1–7.
        65. Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, Mosaddegh M, et al. Heart palpitation relief with Melissa officinalis leaf extract: Double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol. 2015 Apr;164:378–84.
        66. Asadi A, shidfar F, Safari M, Malek M, Hosseini AF, Rezazadeh S, et al. Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial. Complement Ther Med. 2018 Oct;40:83–8.
        67. Fathiazad F, Matlobi A, Khorrami A, Hamedeyazdan S, Soraya H, Hammami M, et al. Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats. DARU Journal of Pharmaceutical Sciences. 2012 Dec 5;20(1):87.
        68. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem. 2001 Sep;225(1-):75–83.
        69. Singh S. Mechanism of action of antiinflammatory effect of fixed oil of Ocimum basilicum Linn. Indian J Exp Biol. 1999 Mar;37(3):248–52.
        70. Kavitha S, John F, Indira M. Amelioration of inflammation by phenolic rich methanolic extract of Ocimum sanctum Linn. leaves in isoproterenol induced myocardial infarction. Indian J Exp Biol. 2015 Oct;53(10):632–40.
        71. Ramadan G, El-Beih NM, Arafa NMS, Zahra MM. Preventive Effects of Egyptian Sweet Marjoram (Origanum majorana L.) Leaves on Haematological Changes and Cardiotoxicity in Isoproterenol-Treated Albino Rats. Cardiovasc Toxicol. 2013 Jun 10;13(2):100–9.
        72. Cheng C, Zou Y, Peng J. Oregano Essential Oil Attenuates RAW264.7 Cells from Lipopolysaccharide-Induced Inflammatory Response through Regulating NADPH Oxidase Activation-Driven Oxidative Stress. Molecules. 2018 Jul 26;23(8):1857.
        73. Chuang LT, Tsai TH, Lien TJ, Huang WC, Liu JJ, Chang H, et al. Ethanolic Extract of Origanum vulgare Suppresses Propionibacterium acnes-Induced Inflammatory Responses in Human Monocyte and Mouse Ear Edema Models. Molecules. 2018 Aug 9;23(8):1987.
        74. Kapewangolo P, Hussein AA, Meyer D. Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus. J Ethnopharmacol. 2013 Aug;149(1):184–90.
        75. Akinbo DB, Onyeaghala AA, Emomidue JO, Ogbhemhe SO, Okpoli HC. Phytochemical and anti-inflammatory activities of aqueous leaf extract of Indian borage (oregano) on rats induced with inflammation. Cancer Biomarkers. 2018 May 29;22(2):257–65.
        76. Napagoda M, Gasometer J, Wesely S, Popella S, Lorenz S, Scheubert K, et al. Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approach. J Ethnopharmacol. 2014 Feb;151(2):800–9.
        77. Murino Rafacho BP, Portugal dos Santos P, Gonçalves A de F, Fernandes AAH, Okoshi K, Chiuso-Minicucci F, et al. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats. PLoS One. 2017 May 11;12(5):e0177521.
        78. Liu X, Pan L, Gong Q, Zhu Y. Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol. 2010 Dec;649(1–3):236–41.
        79. Liu X hua, Chen P fang, Pan L long, Silva R De, Zhu Y zhun. 4-Guanidino-n-butyl Syringate (Leonurine, SCM 198) Protects H9c2 Rat Ventricular Cells From Hypoxia-induced Apoptosis. J Cardiovasc Pharmacol. 2009 Nov;54(5):437–44.
        80. Xu L, Jiang X, Wei F, Zhu H. Leonurine protects cardiac function following acute myocardial infarction through anti apoptosis by the PI3K/AKT/GSK3β signaling pathway. Mol Med Rep. 2018 May 29;
        81. Javidanpour S, Dianat M, Badavi M, Mard SA. The cardioprotective effect of rosmarinic acid on acute myocardial infarction and genes involved in Ca 2+ homeostasis. Free Radic Res. 2017 Dec 2;51(11–12):911–23.
        82. Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, et al. Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling. Cellular Physiology and Biochemistry. 2018;47(3):1193–206.
        83. Mahajan U, Chandrayan G, Patil C, Arya D, Suchal K, Agrawal Y, et al. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway. Int J Mol Sci. 2017 Apr 4;18(4):756.
        84. Yu W, Sun H, Zha W, Cui W, Xu L, Min Q, et al. Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway. Evid Based Complement Alternat Med. 2017;2017:2590676.
        85. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 2003 Feb;301(4):1069–78.
        86. Kaneider NC, Mosheimer B, Reinisch N, Patsch JR, Wiedermann CJ. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet–neutrophil interactions. Thromb Res. 2004;114(3):185–94.
        87. Chi? IC, Baltaru D, Dumitrovici A, Coseriu A, Radu BC, Moldovan R, et al. Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat’s heart. Physiol Int. 2018 Sep 1;105(3):233–46.
        88. Ahmed LA, Salem HA, Attia AS, El-Sayed ME. Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. J Pharm Pharmacol. 2009 Sep;61(9):1233–41.
        89. Yu W, Liu Q, Zhu S. Carvacrol Protects against Acute Myocardial Infarction of Rats via Anti-oxidative and Anti-apoptotic Pathways. Biol Pharm Bull. 2013;36(4):579–84.
        90. Chen Y, Ba L, Huang W, Liu Y, Pan H, Mingyao E, et al. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Eur J Pharmacol. 2017 Feb;796:90–100.
        91. Xiao J, Ke Z, Shi Y, Zeng Q, Cao Z. The cardioprotective effect of thymoquinone on ischemia?reperfusion injury in isolated rat heart via regulation of apoptosis and autophagy. J Cell Biochem. 2018 Sep 22;119(9):7212–7.
        92. Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, et al. Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling. Cellular Physiology and Biochemistry. 2018;47(3):1193–206.
        93. Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, et al. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats. Pulm Pharmacol Ther. 2018 Feb;48:124–35.
        94. Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Lahkar M. Baicalein protects isoproterenol induced myocardial ischemic injury in male Wistar rats by mitigating oxidative stress and inflammation. Inflammation Research. 2016 Aug 12;65(8):613–22.
        95. Cui G, Chui Wah Luk S, Li RA, Chan KKK, Lei SW, Wang L, et al. Cytoprotection of Baicalein Against Oxidative Stress-induced Cardiomyocytes Injury Through the Nrf2/Keap1 Pathway. J Cardiovasc Pharmacol. 2015 Jan;65(1):39–46.
        96. Zhao F, Fu L, Yang W, Dong Y, Yang J, Sun S, et al. Cardioprotective effects of baicalein on heart failure via modulation of Ca2+ handling proteins in vivo and in vitro. Life Sci. 2016 Jan;145:213–23.
        97. Al-Snafi PDAE. Medicinal plants for prevention and treatment of cardiovascular diseases - A review. IOSR Journal of Pharmacy (IOSRPHR). 2017 Apr;07(04):103–63.
        98. Petkov V. Plants and hypotensive, antiatheromatous and coronarodilatating action. Am J Chin Med (Gard City N Y). 1979;7(3):197–236.
        99. Al-Qattan KK, Alnaqeeb MA, Ali M. The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney--one-clip Goldblatt model. J Ethnopharmacol. 1999 Aug;66(2):217–22.
        100. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids. 2000 Apr;62(4):253–9.
        101. Fallon MB, Abrams GA, Abdel-Razek TT, Dai J, Chen SJ, Chen YF, et al. Garlic prevents hypoxic pulmonary hypertension in rats. Am J Physiol. 1998 Aug;275(2):L283-7.
        102. Al-Snafi AE. The Pharmaceutical Importance of Althaea officinalis and Althaea rosea?: A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
        103. Duarte J, Pérez-Vizcaíno F, Torres AI, Zarzuelo A, Jiménez J, Tamargo J. Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur J Pharmacol. 1995 Nov 14;286(2):115–22.
        104. Durate J, Vallejo I, Pérez-Vizcaino F, Jiménez R, Zarzuelo A, Tamargo J. Effects of visnadine on rat isolated vascular smooth muscles. Planta Med. 1997 Jun;63(3):233–6.
        105. Duarte J, Torres AI, Zarzuelo A. Cardiovascular effects of visnagin on rats. Planta Med. 2000 Feb;66(1):35–9.
        106. Gbadamosi IT, Opatola DG, Oyagbemi A, Ajibade TO, Bolaji-Alabi FB, Omobowale TO, et al. Methanol extract of Caesalpinia benthamiana normalizes blood pressure and attenuates oxidative stress in uninephrectomized hypertensive rats. J Basic Clin Physiol Pharmacol. 2020 Sep 14;32(2):109–19.
        107. Yust MM, Pedroche J, Girón-Calle J, Alaiz M, Millán F, Vioque J. Production of ace inhibitory peptides by digestion of chickpea legumin with alcalase. Food Chem. 2003 Jun;81(3):363–9.
        108. Al-Snafi AE. The medical Importance of Cicer arietinum-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
        109. Sivakrishnan S, Pradeepraj D. GAS CHROMATOGRAPHY-MASS SPECTROSCOPY ANALYSIS OF ETHANOLIC EXTRACT OF LEAVES OF CORDIA OBLIQUA WILLD. 2019;12. Available from: http://dx.doi.org/10.22159/ajpcr.2019.v12i6.33298
        110. Al-Snafi AE. The Pharmacological and therapeutic importance of Cordia myxa-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
        111. Jabeen Q, Bashir S, Lyoussi B, Gilani AH. Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities. J Ethnopharmacol. 2009 Feb 25;122(1):123–30.
        112. Al-Snafi AE. A review on chemical constituents and pharmacological activities of Coriandrum sativum [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
        113. Liu N, Yang Y, Mo S, Liao J, Jin J. Calcium antagonistic effects of Chinese crude drugs: preliminary investigation and evaluation by 45 Ca. Appl Radiat Isot. 2005 Aug;63(2):151–5.
        114. Al-Snafi AE. Nutritional and therapeutic importance of Daucus carota-A review [Internet]. Vol. 7, IOSR Journal Of Pharmacy www.iosrphr.org. 2017. Available from: www.iosrphr.org
        115. Al-Snafi AE. Nutritional and therapeutic importance of Daucus carota-A review [Internet]. Vol. 7, IOSR Journal Of Pharmacy www.iosrphr.org. 2017. Available from: www.iosrphr.org
        116. Cheeke PR. Toxicants of Plant Origin. Boca Raton: CRC Press; 2023.
        117. Ver. Weed Risk Assessment for Adonis aestivalis (Pheasant’s eye). 2019.
        118. Marashdah MS, AL-Hazimi HM. Pharmacological activity of ethanolic extract of Alhagi maurorum roots. Arabian Journal of Chemistry. 2010 Jan;3(1):39–42.
        119. Al-Snafi AE. ALHAGI MAURORUM AS A POTENTIAL MEDICINAL HERB: AN OVERVIEW [Internet]. Vol. 2. 2015. Available from: www.ijprr.com
        120. Al-Snafi AE. The Pharmaceutical Importance of Althaea officinalis and Althaea rosea?: A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
        121. Ürünler AB. H?ltan tohumunun (Umbelliferae, Ammi visnaga L.) düz kaslar üzerine etkisi Ba?ar ALTINTER?M.
        122. WHO monographs on selected medicinal plants. Vol. 3. World Health Organization; 2007. 376 p.
        123. Rathi L. Presidential address at annual conference of Indian Psychiatric Society, Kochi (2024). Indian J Psychiatry. 2024 Jun;66(6):493–4.
        124. Yusup A, Upur H, Baudrimont I, Umar A, Berke B, Yimit D, et al. Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine. Evidence-based Complementary and Alternative Medicine. 2011;2011.
        125. Mahran GH, Kadry HA, Isaac ZG, Thabet CK, Al?Azizi MM, El?Olemy MM. Investigation of diuretic drug plants. 1. Phytochemical screening and pharmacological evaluation of Anethum graveolens L., Apium graveolens L., Daucus carota L. and Eruca sativa mill. Phytotherapy Research. 1991 Aug 31;5(4):169–72.
        126. Rashid S, Lodhi F, Ahmad M, Usmanghani K. Cardiovascular effects of Bacopa monnieri (L.) pennel extract in rabbits. Pak J Pharm Sci. 1990 Jul;3(2):57–62.
        127. Wickes H. monographs extracted from The Eclectic Materia Medica, Pharmacology and Therapeutics.
        128. Javed A, Ahmad A, Nouman M, Hameed A, Tahir A, Shabbir U. Turnip (Brassica Rapus L.): a natural health tonic. Brazilian Journal of Food Technology. 2019;22.
        129. Ray D, Mukherjee S, Falchi M, Bertelli A, Das DK. Amelioration of myocardial ischemic reperfusion injury with Calendula officinalis. Curr Pharm Biotechnol. 2010 Dec;11(8):849–54.
        130. Mueen Ahmed KK, Rana AC, Dixit VK. Effect of Calotropis procera latex on isoproterenol induced myocardial infarction in albino rats. Phytomedicine. 2004 Jan;11(4):327–30.
        131. Han SY, Li HX, Ma X, Zhang K, Ma ZZ, Tu PF. Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro. Phytomedicine. 2009 Aug;16(8):694–702.
        132. Wan LH, Chen J, Li L, Xiong WB, Zhou LM. Protective effects of Carthamus tinctorius injection on isoprenaline-induced myocardial injury in rats. Pharm Biol. 2011 Nov;49(11):1204–9.
        133. Lei ZH, Kuniyasu A, Tai BS, Nakayama H, Nohara T. Na+,K(+)-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides. Planta Med. 2001 Jun;67(4):369–70.
        134. Rashmika P. CARDIOTONIC ACTIVITY OF ISOLATED CARDIAC GLYCOSIDE FROM THE FRUITS OF CORCHORUS AESTUANS LINN [Internet]. Vol. 2012, IRJP. Available from: www.irjponline.com
        135. 2. Int J Pharm Sci Res. 9(9).
        136. Al-Snafi AE. The contents and pharmacological importance of Corchorus capsularis-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
        137. Al-Snafi AE. The contents and pharmacological importance of Corchorus capsularis-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
        138. Negm S, El-Shabrawy O, Arbid M, Radwan AS. Toxicological study of the different organs of Corchorus olitorius L. plant with special reference to their cardiac glycosides content. Z Ernahrungswiss. 1980 Mar;19(1):28–32.
        139. Slavík J, Zácková P, Michlová J, Opletal L, Sovová M. [Phytotherapeutic aspects of diseases of the circulatory system. III. Cardiotonic and cardiotoxic effects of hyrcanoside and deglucohyrcanoside isolated from Coronilla varia L]. Ceska Slov Farm. 1994 Nov;43(6):298–302.
        140. Al-Snafi AE. 7092 CODEN(USA): PCJHBA The Pharmacological and Toxicological Effects of Coronilla varia and Coronilla scorpioides: A Review [Internet]. Vol. 3, The Pharmaceutical and Chemical Journal. 2016. Available from: www.tpcj.org
        141. Gersl V. [Effects of Coronilla varia Linné extract and lanatoside C in rabbits with experimental acute heart overloading in vivo]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl. 1980;23(4):445–57.
        142. 15.Erodium cicutarium.
        143. Lis-Balchin MT, Hart SL. A Pharmacological Appraisal of the Folk Medicinal Usage of Pelargonium grossularioides and Erodium cicutarium. J Herbs Spices Med Plants. 1994 Nov 11;2(3):41–8.
        144. Al-Snafi AE. Chemical Constituents and Pharmacological Activities of Milfoil (Achillea santolina). A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
        145. Balbaa SI, Zaki AY, Abdel-Wahab SM, el-Denshary ES, Motazz-Bellah M. Preliminary phytochemical and pharmacological investigations of the roots of different varieties of Cichorium intybus. Planta Med. 1973 Oct;24(2):133–44.

Reference

  1. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Review Article Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review [Internet]. Vol. 7, Am J Cardiovasc Dis. 2017. Available from: www.AJCD.us/
  2. Khan J, Deb PK, Priya S, Medina KD, Devi R, Walode SG, et al. Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Vol. 26, Molecules. MDPI AG; 2021.
  3. Griffiths K, Aggarwal B, Singh R, Buttar H, Wilson D, De Meester F. Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases. 2016 Aug 1;4(3):28.
  4. Ashish Tilak-Jain J, Paul Asir Devasagayam T. Cardioprotective and Other Beneficial Effects of Some Indian Medicinal Plants. Vol. 38, J. Clin. Biochem. Nutr. 2006.
  5. and Alternative Medicine EBC. Retracted: Prevention and Treatment of Cardiovascular Diseases with Plant Phytochemicals: A Review. Evidence-Based Complementary and Alternative Medicine. 2023 Jan;2023(1).
  6. Jain S, Buttar HS, Chintameneni M, Kaur G. Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies. Recent Pat Inflamm Allergy Drug Discov. 2018 Aug 30;12(2):145–57.
  7. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine (CCLM). 2020 Jun 25;58(7):1131–4.
  8. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology. 2020 May 11;109(5):531–8.
  9. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020 Mar;395(10229):1054–62.
  10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb;395(10223):497–506.
  11. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061.
  12. Nabel EG. Cardiovascular Disease. New England Journal of Medicine. 2003 Jul 3;349(1):60–72.
  13. G N, SANDUR V R. CARDIOPROTECTIVE POTENTIAL OF PLANTS AND PLANT-DERIVED PRINCIPLES – A REVIEW. Asian Journal of Pharmaceutical and Clinical Research. 2019 Feb 15;46–56.
  14. Ojha S, Bharti S, Sharma AK, Rani N, Bhatia J, Kumari S, et al. Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction. Indian J Biochem Biophys. 2011 Feb;48(1):22–8.
  15. Kumar AH, Javed A, Jaiswal M, Talkad MS. Cardioprotective Effects in Methanolic Extract of Evolvulus Alsinoides Linn on Isoproterenol-Induced Myocardial Infarction in Albino Rats [Internet]. Vol. 2, International Journal of Basic Medical Sciences and Pharmacy (IJBMSP). 2012. Available from: www.sciacademypublisher.com53
  16. Angeloni C, Spencer JPE, Leoncini E, Biagi PL, Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie. 2007 Jan;89(1):73–82.
  17. Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004 Oct;52:794–804.
  18. You J, Pan T, Lee Y. Protective effects of Danshen ( Salvia Miltiorrhiza ) on adriamycin?induced cardiac and hepatic toxicity in rats. Phytotherapy Research. 2007 Dec 18;21(12):1146–52.
  19. Jahan N, And KUR, Ali S. Cardioprotective and Antilipidemic Potential of Cyperus rotundus in Chemically Induced Cardiotoxicity. Int J Agric Biol [Internet]. 2012; Available from: http://www.fspublishers.org
  20. Keevil JG, Osman HE, Reed JD, Folts JD. Grape Juice, But Not Orange Juice or Grapefruit Juice, Inhibits Human Platelet Aggregation. J Nutr. 2000 Jan;130(1):53–6.
  21. Fathiazad F, Matlobi A, Khorrami A, Hamedeyazdan S, Soraya H, Hammami M, et al. Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats. DARU Journal of Pharmaceutical Sciences. 2012 Dec 5;20(1):87.
  22. Harnafi H, Serghini Caid H, el Houda Bouanani N, Aziz M, Amrani S. Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in Triton WR-1339-induced hyperlipidemic mice. Food Chem. 2008 May;108(1):205–12.
  23. Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: the good, the bad and the ugly. Phytotherapy Research. 2003 Feb 10;17(2):97–106.
  24. Maslin DJ, Brown CA, Das I, Zhang XH. Nitric oxide - a mediator of the effects of garlic? Biochem Soc Trans. 1997 Aug 1;25(3):408S-408S.
  25. SOORANNA SR, HIRANI J, DAS I. Garlic can induce both GTP cyclohydrolase and nitric oxide synthase activity in choriocarcinoma cells. Biochem Soc Trans. 1995 Nov 1;23(4):543S-543S.
  26. Adegbola P, Aderibigbe I, Hammed W, Omotayo T. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am J Cardiovasc Dis. 2017;7(2):19–32.
  27. Shackebaei D, Godini A, Pilehvarian A. Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion. 2010.
  28. Kumar AH, Javed A, Jaiswal M, Talkad MS. Cardioprotective Effects in Methanolic Extract of Evolvulus Alsinoides Linn on Isoproterenol-Induced Myocardial Infarction in Albino Rats [Internet]. Vol. 2, International Journal of Basic Medical Sciences and Pharmacy (IJBMSP). 2012. Available from: www.sciacademypublisher.com53
  29. Naik SR, Pilgaonkar VW, Panda VS. Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain. Phytotherapy Research. 2006 Nov 14;20(11):1013–6.
  30. Uma Devi P, Ganasoundari A, Vrinda B, Srinivasan KK, Unnikrishnan MK. Radiation protection by the ocimum flavonoids orientin and vicenin: mechanisms of action. Radiat Res. 2000 Oct;154(4):455–60.
  31. Panda VS, N SR. Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents. Altern Med Rev. 2009 Jun;14(2):161–71.
  32. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 2007 Feb;147(2):227–35.
  33. Anosike CA, Obidoa O, Ezeanyika LU. Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (Solanum aethiopicum). Daru. 2012 Nov 14;20(1):76.
  34. Libby P. Vascular biology of atherosclerosis: overview and state of the art. Am J Cardiol. 2003 Feb 6;91(3A):3A-6A.
  35. Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009 Feb;11(2):119–29.
  36. Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul;15(4):331–41.
  37. Lee CH, Kim JH. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. Vol. 38, Journal of Ginseng Research. Elsevier B.V.; 2014. p. 161–6.
  38. Candia AM de, Villacorta H, Mesquita ET. Immune-inflammatory activation in heart failure. Arq Bras Cardiol. 2007 Sep;89(3):183–90, 201–8.
  39. Scalia R, Appel JZ, Lefer AM. Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1. Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1093–100.
  40. Stokes KY, Calahan L, Russell JM, Gurwara S, Granger DN. Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation. 2006;13(5):377–88.
  41. Stapleton PA, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond). 2010 Nov 18;7:54.
  42. Wallace TC. Anthocyanins in cardiovascular disease. Adv Nutr. 2011 Jan;2(1):1–7.
  43. Kadian R, Parle M. INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Therapeutic potential and phytopharmacology of tulsi. Int J of Pharm & Life Sci (IJPLS). 2012;3(7):1858–67.
  44. Ahlawat B, Om D, Sharma P, Scholar PG. PHARMACOLOGICAL ACTIVITIES OF OCIMUM SANCTUM (TULSI): A REVIEW [Internet]. Available from: www.wjpmr.com
  45. Singh S, Majumdar DK. Evaluation of antiinflammatory activity of fatty acids of Ocimum sanctum fixed oil. Indian J Exp Biol. 1997 Apr;35(4):380–3.
  46. Xing L, Jiang M, Dong L, Gao J, Hou Y, Bai G, et al. Cardioprotective effects of the YiQiFuMai injection and isolated compounds on attenuating chronic heart failure via NF-κB inactivation and cytokine suppression. J Ethnopharmacol. 2013 Jun 21;148(1):239–45.
  47. Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu B, et al. Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol Pharm Bull. 2005 Jul;28(7):1234–8.
  48. Lee DCW, Lau ASY. Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: a mini-review. Molecules. 2011 Mar 30;16(4):2802–16.
  49. Lü JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009 Jul;7(3):293–302.
  50. Oh SY, Kim YH, Bae DS, Um BH, Pan CH, Kim CY, et al. Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci Biotechnol Biochem. 2010;74(2):285–91.
  51. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10.
  52. Yeh ETH, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003 Jan 28;107(3):370–1.
  53. Ziaee M, Khorrami A, Ebrahimi M, Nourafcan H, Amiraslanzadeh M, Rameshrad M, et al. Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat. Iran J Pharm Res. 2015;14(1):279–89.
  54. Kulabas SS, Ipek H, Tufekci AR, Arslan S, Demirtas I, Ekren R, et al. Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. J Ethnopharmacol. 2018 Sep 15;223:88–98.
  55. Wojtyniak K, Szyma?ski M, Mat?awska I. Leonurus cardiaca L. (Motherwort): A Review of its Phytochemistry and Pharmacology. Phytotherapy Research. 2013 Aug 8;27(8):1115–20.
  56. Sadowska B, Micota B, Ró?alski M, Redzynia M, Ró?alski M. The immunomodulatory potential of Leonurus cardiaca extract in relation to endothelial cells and platelets. Innate Immun. 2017 Apr 31;23(3):285–95.
  57. Yousefi K, Soraya H, Fathiazad F, Khorrami A, Hamedeyazdan S, Maleki-Dizaji N, et al. Cardioprotective effect of methanolic extract of Marrubium vulgare L. on isoproterenol-induced acute myocardial infarction in rats. Indian J Exp Biol. 2013 Aug;51(8):653–60.
  58. Garjani A, Tila D, Hamedeyazdan S, Vaez H, Rameshrad M, Pashaii M, et al. An investigation on cardioprotective potential of Marrubium vulgare aqueous fraction against ischaemia-reperfusion injury in isolated rat heart. Folia Morphol (Warsz). 2017 Sep 7;76(3):361–71.
  59. Zaidi SF, Muhammad JS, Shahryar S, Usmanghani K, Gilani AH, Jafri W, et al. Anti-inflammatory and cytoprotective effects of selected Pakistani medicinal plants in Helicobacter pylori-infected gastric epithelial cells. J Ethnopharmacol. 2012 May;141(1):403–10.
  60. Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998 Mar;60(2):117–24.
  61. Modarresi M, Farahpour MR, Baradaran B. Topical application of Mentha piperita essential oil accelerates wound healing in infected mice model. Inflammopharmacology. 2019 Jun 6;27(3):531–7.
  62. Mani Badal R, Badal D, Badal P, Khare A, Shrivastava J, Kumar V. Pharmacological Action of Mentha piperita on Lipid Profile in Fructose-Fed Rats. Iran J Pharm Res. 2011;10(4):843–8.
  63. Brahmi F, Nury T, Debbabi M, Hadj-Ahmed S, Zarrouk A, Prost M, et al. Evaluation of Antioxidant, Anti-Inflammatory and Cytoprotective Properties of Ethanolic Mint Extracts from Algeria on 7-Ketocholesterol-Treated Murine RAW 264.7 Macrophages. Antioxidants. 2018 Dec 6;7(12):184.
  64. Bounihi A, Hajjaj G, Alnamer R, Cherrah Y, Zellou A. In Vivo Potential Anti-Inflammatory Activity of Melissa officinalis L. Essential Oil. Adv Pharmacol Sci. 2013;2013:1–7.
  65. Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, Mosaddegh M, et al. Heart palpitation relief with Melissa officinalis leaf extract: Double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol. 2015 Apr;164:378–84.
  66. Asadi A, shidfar F, Safari M, Malek M, Hosseini AF, Rezazadeh S, et al. Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial. Complement Ther Med. 2018 Oct;40:83–8.
  67. Fathiazad F, Matlobi A, Khorrami A, Hamedeyazdan S, Soraya H, Hammami M, et al. Phytochemical screening and evaluation of cardioprotective activity of ethanolic extract of Ocimum basilicum L. (basil) against isoproterenol induced myocardial infarction in rats. DARU Journal of Pharmaceutical Sciences. 2012 Dec 5;20(1):87.
  68. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem. 2001 Sep;225(1-):75–83.
  69. Singh S. Mechanism of action of antiinflammatory effect of fixed oil of Ocimum basilicum Linn. Indian J Exp Biol. 1999 Mar;37(3):248–52.
  70. Kavitha S, John F, Indira M. Amelioration of inflammation by phenolic rich methanolic extract of Ocimum sanctum Linn. leaves in isoproterenol induced myocardial infarction. Indian J Exp Biol. 2015 Oct;53(10):632–40.
  71. Ramadan G, El-Beih NM, Arafa NMS, Zahra MM. Preventive Effects of Egyptian Sweet Marjoram (Origanum majorana L.) Leaves on Haematological Changes and Cardiotoxicity in Isoproterenol-Treated Albino Rats. Cardiovasc Toxicol. 2013 Jun 10;13(2):100–9.
  72. Cheng C, Zou Y, Peng J. Oregano Essential Oil Attenuates RAW264.7 Cells from Lipopolysaccharide-Induced Inflammatory Response through Regulating NADPH Oxidase Activation-Driven Oxidative Stress. Molecules. 2018 Jul 26;23(8):1857.
  73. Chuang LT, Tsai TH, Lien TJ, Huang WC, Liu JJ, Chang H, et al. Ethanolic Extract of Origanum vulgare Suppresses Propionibacterium acnes-Induced Inflammatory Responses in Human Monocyte and Mouse Ear Edema Models. Molecules. 2018 Aug 9;23(8):1987.
  74. Kapewangolo P, Hussein AA, Meyer D. Inhibition of HIV-1 enzymes, antioxidant and anti-inflammatory activities of Plectranthus barbatus. J Ethnopharmacol. 2013 Aug;149(1):184–90.
  75. Akinbo DB, Onyeaghala AA, Emomidue JO, Ogbhemhe SO, Okpoli HC. Phytochemical and anti-inflammatory activities of aqueous leaf extract of Indian borage (oregano) on rats induced with inflammation. Cancer Biomarkers. 2018 May 29;22(2):257–65.
  76. Napagoda M, Gasometer J, Wesely S, Popella S, Lorenz S, Scheubert K, et al. Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approach. J Ethnopharmacol. 2014 Feb;151(2):800–9.
  77. Murino Rafacho BP, Portugal dos Santos P, Gonçalves A de F, Fernandes AAH, Okoshi K, Chiuso-Minicucci F, et al. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats. PLoS One. 2017 May 11;12(5):e0177521.
  78. Liu X, Pan L, Gong Q, Zhu Y. Leonurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur J Pharmacol. 2010 Dec;649(1–3):236–41.
  79. Liu X hua, Chen P fang, Pan L long, Silva R De, Zhu Y zhun. 4-Guanidino-n-butyl Syringate (Leonurine, SCM 198) Protects H9c2 Rat Ventricular Cells From Hypoxia-induced Apoptosis. J Cardiovasc Pharmacol. 2009 Nov;54(5):437–44.
  80. Xu L, Jiang X, Wei F, Zhu H. Leonurine protects cardiac function following acute myocardial infarction through anti apoptosis by the PI3K/AKT/GSK3β signaling pathway. Mol Med Rep. 2018 May 29;
  81. Javidanpour S, Dianat M, Badavi M, Mard SA. The cardioprotective effect of rosmarinic acid on acute myocardial infarction and genes involved in Ca 2+ homeostasis. Free Radic Res. 2017 Dec 2;51(11–12):911–23.
  82. Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, et al. Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling. Cellular Physiology and Biochemistry. 2018;47(3):1193–206.
  83. Mahajan U, Chandrayan G, Patil C, Arya D, Suchal K, Agrawal Y, et al. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway. Int J Mol Sci. 2017 Apr 4;18(4):756.
  84. Yu W, Sun H, Zha W, Cui W, Xu L, Min Q, et al. Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway. Evid Based Complement Alternat Med. 2017;2017:2590676.
  85. Moon SK, Cho GO, Jung SY, Gal SW, Kwon TK, Lee YC, et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem Biophys Res Commun. 2003 Feb;301(4):1069–78.
  86. Kaneider NC, Mosheimer B, Reinisch N, Patsch JR, Wiedermann CJ. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet–neutrophil interactions. Thromb Res. 2004;114(3):185–94.
  87. Chi? IC, Baltaru D, Dumitrovici A, Coseriu A, Radu BC, Moldovan R, et al. Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat’s heart. Physiol Int. 2018 Sep 1;105(3):233–46.
  88. Ahmed LA, Salem HA, Attia AS, El-Sayed ME. Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. J Pharm Pharmacol. 2009 Sep;61(9):1233–41.
  89. Yu W, Liu Q, Zhu S. Carvacrol Protects against Acute Myocardial Infarction of Rats via Anti-oxidative and Anti-apoptotic Pathways. Biol Pharm Bull. 2013;36(4):579–84.
  90. Chen Y, Ba L, Huang W, Liu Y, Pan H, Mingyao E, et al. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways. Eur J Pharmacol. 2017 Feb;796:90–100.
  91. Xiao J, Ke Z, Shi Y, Zeng Q, Cao Z. The cardioprotective effect of thymoquinone on ischemia?reperfusion injury in isolated rat heart via regulation of apoptosis and autophagy. J Cell Biochem. 2018 Sep 22;119(9):7212–7.
  92. Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, et al. Thymoquinone Attenuates Myocardial Ischemia/Reperfusion Injury Through Activation of SIRT1 Signaling. Cellular Physiology and Biochemistry. 2018;47(3):1193–206.
  93. Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, et al. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats. Pulm Pharmacol Ther. 2018 Feb;48:124–35.
  94. Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Lahkar M. Baicalein protects isoproterenol induced myocardial ischemic injury in male Wistar rats by mitigating oxidative stress and inflammation. Inflammation Research. 2016 Aug 12;65(8):613–22.
  95. Cui G, Chui Wah Luk S, Li RA, Chan KKK, Lei SW, Wang L, et al. Cytoprotection of Baicalein Against Oxidative Stress-induced Cardiomyocytes Injury Through the Nrf2/Keap1 Pathway. J Cardiovasc Pharmacol. 2015 Jan;65(1):39–46.
  96. Zhao F, Fu L, Yang W, Dong Y, Yang J, Sun S, et al. Cardioprotective effects of baicalein on heart failure via modulation of Ca2+ handling proteins in vivo and in vitro. Life Sci. 2016 Jan;145:213–23.
  97. Al-Snafi PDAE. Medicinal plants for prevention and treatment of cardiovascular diseases - A review. IOSR Journal of Pharmacy (IOSRPHR). 2017 Apr;07(04):103–63.
  98. Petkov V. Plants and hypotensive, antiatheromatous and coronarodilatating action. Am J Chin Med (Gard City N Y). 1979;7(3):197–236.
  99. Al-Qattan KK, Alnaqeeb MA, Ali M. The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney--one-clip Goldblatt model. J Ethnopharmacol. 1999 Aug;66(2):217–22.
  100. Ali M, Al-Qattan KK, Al-Enezi F, Khanafer RM, Mustafa T. Effect of allicin from garlic powder on serum lipids and blood pressure in rats fed with a high cholesterol diet. Prostaglandins Leukot Essent Fatty Acids. 2000 Apr;62(4):253–9.
  101. Fallon MB, Abrams GA, Abdel-Razek TT, Dai J, Chen SJ, Chen YF, et al. Garlic prevents hypoxic pulmonary hypertension in rats. Am J Physiol. 1998 Aug;275(2):L283-7.
  102. Al-Snafi AE. The Pharmaceutical Importance of Althaea officinalis and Althaea rosea?: A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
  103. Duarte J, Pérez-Vizcaíno F, Torres AI, Zarzuelo A, Jiménez J, Tamargo J. Vasodilator effects of visnagin in isolated rat vascular smooth muscle. Eur J Pharmacol. 1995 Nov 14;286(2):115–22.
  104. Durate J, Vallejo I, Pérez-Vizcaino F, Jiménez R, Zarzuelo A, Tamargo J. Effects of visnadine on rat isolated vascular smooth muscles. Planta Med. 1997 Jun;63(3):233–6.
  105. Duarte J, Torres AI, Zarzuelo A. Cardiovascular effects of visnagin on rats. Planta Med. 2000 Feb;66(1):35–9.
  106. Gbadamosi IT, Opatola DG, Oyagbemi A, Ajibade TO, Bolaji-Alabi FB, Omobowale TO, et al. Methanol extract of Caesalpinia benthamiana normalizes blood pressure and attenuates oxidative stress in uninephrectomized hypertensive rats. J Basic Clin Physiol Pharmacol. 2020 Sep 14;32(2):109–19.
  107. Yust MM, Pedroche J, Girón-Calle J, Alaiz M, Millán F, Vioque J. Production of ace inhibitory peptides by digestion of chickpea legumin with alcalase. Food Chem. 2003 Jun;81(3):363–9.
  108. Al-Snafi AE. The medical Importance of Cicer arietinum-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
  109. Sivakrishnan S, Pradeepraj D. GAS CHROMATOGRAPHY-MASS SPECTROSCOPY ANALYSIS OF ETHANOLIC EXTRACT OF LEAVES OF CORDIA OBLIQUA WILLD. 2019;12. Available from: http://dx.doi.org/10.22159/ajpcr.2019.v12i6.33298
  110. Al-Snafi AE. The Pharmacological and therapeutic importance of Cordia myxa-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
  111. Jabeen Q, Bashir S, Lyoussi B, Gilani AH. Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities. J Ethnopharmacol. 2009 Feb 25;122(1):123–30.
  112. Al-Snafi AE. A review on chemical constituents and pharmacological activities of Coriandrum sativum [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
  113. Liu N, Yang Y, Mo S, Liao J, Jin J. Calcium antagonistic effects of Chinese crude drugs: preliminary investigation and evaluation by 45 Ca. Appl Radiat Isot. 2005 Aug;63(2):151–5.
  114. Al-Snafi AE. Nutritional and therapeutic importance of Daucus carota-A review [Internet]. Vol. 7, IOSR Journal Of Pharmacy www.iosrphr.org. 2017. Available from: www.iosrphr.org
  115. Al-Snafi AE. Nutritional and therapeutic importance of Daucus carota-A review [Internet]. Vol. 7, IOSR Journal Of Pharmacy www.iosrphr.org. 2017. Available from: www.iosrphr.org
  116. Cheeke PR. Toxicants of Plant Origin. Boca Raton: CRC Press; 2023.
  117. Ver. Weed Risk Assessment for Adonis aestivalis (Pheasant’s eye). 2019.
  118. Marashdah MS, AL-Hazimi HM. Pharmacological activity of ethanolic extract of Alhagi maurorum roots. Arabian Journal of Chemistry. 2010 Jan;3(1):39–42.
  119. Al-Snafi AE. ALHAGI MAURORUM AS A POTENTIAL MEDICINAL HERB: AN OVERVIEW [Internet]. Vol. 2. 2015. Available from: www.ijprr.com
  120. Al-Snafi AE. The Pharmaceutical Importance of Althaea officinalis and Althaea rosea?: A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
  121. Ürünler AB. H?ltan tohumunun (Umbelliferae, Ammi visnaga L.) düz kaslar üzerine etkisi Ba?ar ALTINTER?M.
  122. WHO monographs on selected medicinal plants. Vol. 3. World Health Organization; 2007. 376 p.
  123. Rathi L. Presidential address at annual conference of Indian Psychiatric Society, Kochi (2024). Indian J Psychiatry. 2024 Jun;66(6):493–4.
  124. Yusup A, Upur H, Baudrimont I, Umar A, Berke B, Yimit D, et al. Inhibition of cell growth and cellular protein, DNA and RNA synthesis in human hepatoma (HepG2) cells by ethanol extract of abnormal Savda Munziq of traditional Uighur medicine. Evidence-based Complementary and Alternative Medicine. 2011;2011.
  125. Mahran GH, Kadry HA, Isaac ZG, Thabet CK, Al?Azizi MM, El?Olemy MM. Investigation of diuretic drug plants. 1. Phytochemical screening and pharmacological evaluation of Anethum graveolens L., Apium graveolens L., Daucus carota L. and Eruca sativa mill. Phytotherapy Research. 1991 Aug 31;5(4):169–72.
  126. Rashid S, Lodhi F, Ahmad M, Usmanghani K. Cardiovascular effects of Bacopa monnieri (L.) pennel extract in rabbits. Pak J Pharm Sci. 1990 Jul;3(2):57–62.
  127. Wickes H. monographs extracted from The Eclectic Materia Medica, Pharmacology and Therapeutics.
  128. Javed A, Ahmad A, Nouman M, Hameed A, Tahir A, Shabbir U. Turnip (Brassica Rapus L.): a natural health tonic. Brazilian Journal of Food Technology. 2019;22.
  129. Ray D, Mukherjee S, Falchi M, Bertelli A, Das DK. Amelioration of myocardial ischemic reperfusion injury with Calendula officinalis. Curr Pharm Biotechnol. 2010 Dec;11(8):849–54.
  130. Mueen Ahmed KK, Rana AC, Dixit VK. Effect of Calotropis procera latex on isoproterenol induced myocardial infarction in albino rats. Phytomedicine. 2004 Jan;11(4):327–30.
  131. Han SY, Li HX, Ma X, Zhang K, Ma ZZ, Tu PF. Protective effects of purified safflower extract on myocardial ischemia in vivo and in vitro. Phytomedicine. 2009 Aug;16(8):694–702.
  132. Wan LH, Chen J, Li L, Xiong WB, Zhou LM. Protective effects of Carthamus tinctorius injection on isoprenaline-induced myocardial injury in rats. Pharm Biol. 2011 Nov;49(11):1204–9.
  133. Lei ZH, Kuniyasu A, Tai BS, Nakayama H, Nohara T. Na+,K(+)-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides. Planta Med. 2001 Jun;67(4):369–70.
  134. Rashmika P. CARDIOTONIC ACTIVITY OF ISOLATED CARDIAC GLYCOSIDE FROM THE FRUITS OF CORCHORUS AESTUANS LINN [Internet]. Vol. 2012, IRJP. Available from: www.irjponline.com
  135. 2. Int J Pharm Sci Res. 9(9).
  136. Al-Snafi AE. The contents and pharmacological importance of Corchorus capsularis-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
  137. Al-Snafi AE. The contents and pharmacological importance of Corchorus capsularis-A review [Internet]. Vol. 6, IOSR Journal Of Pharmacy www.iosrphr.org. 2016. Available from: www.iosrphr.org
  138. Negm S, El-Shabrawy O, Arbid M, Radwan AS. Toxicological study of the different organs of Corchorus olitorius L. plant with special reference to their cardiac glycosides content. Z Ernahrungswiss. 1980 Mar;19(1):28–32.
  139. Slavík J, Zácková P, Michlová J, Opletal L, Sovová M. [Phytotherapeutic aspects of diseases of the circulatory system. III. Cardiotonic and cardiotoxic effects of hyrcanoside and deglucohyrcanoside isolated from Coronilla varia L]. Ceska Slov Farm. 1994 Nov;43(6):298–302.
  140. Al-Snafi AE. 7092 CODEN(USA): PCJHBA The Pharmacological and Toxicological Effects of Coronilla varia and Coronilla scorpioides: A Review [Internet]. Vol. 3, The Pharmaceutical and Chemical Journal. 2016. Available from: www.tpcj.org
  141. Gersl V. [Effects of Coronilla varia Linné extract and lanatoside C in rabbits with experimental acute heart overloading in vivo]. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl. 1980;23(4):445–57.
  142. 15.Erodium cicutarium.
  143. Lis-Balchin MT, Hart SL. A Pharmacological Appraisal of the Folk Medicinal Usage of Pelargonium grossularioides and Erodium cicutarium. J Herbs Spices Med Plants. 1994 Nov 11;2(3):41–8.
  144. Al-Snafi AE. Chemical Constituents and Pharmacological Activities of Milfoil (Achillea santolina). A Review. Vol. 5, International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN.
  145. Balbaa SI, Zaki AY, Abdel-Wahab SM, el-Denshary ES, Motazz-Bellah M. Preliminary phytochemical and pharmacological investigations of the roots of different varieties of Cichorium intybus. Planta Med. 1973 Oct;24(2):133–44.

Photo
Onkar Taur
Corresponding author

SMBT College Of Pharmacy Dhamangaon, Nashik

Photo
Khushal Chaudhari
Co-author

SMBT College Of Pharmacy Dhamangaon, Nashik

Onkar Taur*, Khushal Chaudhari, Nature’s Cure: The Impact of Medicinal Plants on Oxidative Stress and Inflammation in Cardiovascular Diseases, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 3, 3378-3402. https://doi.org/10.5281/zenodo.15113227

More related articles
Phytochemical Profile and Pharmacological Efficacy...
Ishika Dargude, Siddhi Sonawane, Diksha Gangurde, Harshali Dawkha...
Nutraceutical: Medicine of Futures ...
Rutika More , Dimpal Nikam , Sanket More , ...
SPLENOPROTECTIVE EFFECT OF KUDZU ROOT EXTRACT IN A...
Aman Upaganlawar, Sumitkumar Sharma, Aakif Bagwan, Mangesh Tatar,...
A Review On The Role Of Jamun, Syzygium Cumini Skeels In Treatment Of Diabetes...
CHAITANYA BOMBLE , Rekha Goukonde , Dr.Gajanan sanap, ...
Development and Characterization of Neem and Sandalwood based Herbal Face Wash T...
Asalam Patel , Baburao Chandakavathe, Ravishankar Jeure, Irfan Dalwale, Soheb Tamboli, Kunal Gaikwad...
Exploring The Impact of Euphorbia Milii in The Medicine: A Comprehensive Review...
D. Sushma, Vadlamanu Priyanka, Bikkannagari Hari Vardhan, Jellala Pranitha, Hanumadri Nithin, Kulla ...
Related Articles
Unlocking The Biological Potential of Quinolines: A Review ...
Laksmi Gopal R, Sreeja S, Ayshu S, Devika P S, Amina T, Devapriya S, Thrishala Kennady, ...
A Comprehensive Review On Herbal Plants Showing Anti Diabetic Activity...
Saurabh Dumbre, Gaurav Gawade, Swati Jadhav, Pravin Khamkar, ...
A Critical Review On Analytical Methods Used For Quantification Of Indapamide As...
Deep Savsani , Mitali Dalwadi , Chainesh Shah, Umesh Upadhyay, ...
The Study of How Maharashtrian Wild Onion Oil Is Made Assessed, And How Well It ...
Borude Sanket , Ajay Shirsat, Ashok Chopane, Dr. Priyanka Jadhav, Dr. Sanjay Ingle, Sitaram Jadhav, ...
Phytochemical Profile and Pharmacological Efficacy of Terminalia Arjuna: A Detai...
Ishika Dargude, Siddhi Sonawane, Diksha Gangurde, Harshali Dawkhar, Rutuja Daund, Diksha Shinde, ...
More related articles
Phytochemical Profile and Pharmacological Efficacy of Terminalia Arjuna: A Detai...
Ishika Dargude, Siddhi Sonawane, Diksha Gangurde, Harshali Dawkhar, Rutuja Daund, Diksha Shinde, ...
Nutraceutical: Medicine of Futures ...
Rutika More , Dimpal Nikam , Sanket More , ...
SPLENOPROTECTIVE EFFECT OF KUDZU ROOT EXTRACT IN ANILINE INDUCED SPLEEN TOXICITY...
Aman Upaganlawar, Sumitkumar Sharma, Aakif Bagwan, Mangesh Tatar, Chandrashekar Upasani, ...
Phytochemical Profile and Pharmacological Efficacy of Terminalia Arjuna: A Detai...
Ishika Dargude, Siddhi Sonawane, Diksha Gangurde, Harshali Dawkhar, Rutuja Daund, Diksha Shinde, ...
Nutraceutical: Medicine of Futures ...
Rutika More , Dimpal Nikam , Sanket More , ...
SPLENOPROTECTIVE EFFECT OF KUDZU ROOT EXTRACT IN ANILINE INDUCED SPLEEN TOXICITY...
Aman Upaganlawar, Sumitkumar Sharma, Aakif Bagwan, Mangesh Tatar, Chandrashekar Upasani, ...